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A NOVEL CYTOSTATIC FORM OF AUTOPHAGY IN SENSITIZATION OF NON- 
SMALL CELL LUNG CANCER CELLS TO RADIATION BY VITAMIN d AND THE  
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By Khushboo Sharma, PhD 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University. 
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Professor, Pharmacology and Toxicology 
 
 
The standard of care for unresectable lung cancer is chemoradiation. However, 
therapeutic options are limited and patients are rarely cured. While Radiation therapy is 
effective at killing tumor cells or inhibiting their growth initially, development of 
resistance to treatments and recurrence of tumors are major issues. One of the major 
goals of Dr. Gewirtz’s laboratory has been to develop strategies to overcome the 
resistance and attenuate disease recurrence. One of these attempts involve employing 
 
 
XVI 
 
vitamin D and its analogs  in combination with radiation therapy.  Our proposed studies 
were based on a previous finding where vitamin D and vitamin D analogs such as EB 
1089, were shown to enhance the response to radiation in breast cancer through the 
promotion of autophagy.   
We extended these studies to non-small cell lung cancer (NSCLC) and were able to 
validate that 1,25-D3 (the hormonally active form of vitamin D) and EB 1089 does in fact 
sensitize A549 and H460 cells and prolonged the growth arrest induced by radiation 
alone and suppressed proliferative recovery, which translated to a significant reduction 
in clonogenic survival. In H838 or H358 NSCLC cells, which lack the vitamin D receptor 
or functional p53, respectively, 1,25-D3 failed to modify the extent of radiation-induced 
growth arrest or suppress proliferative recovery post irradiation. Sensitization to 
radiation in H1299 NSCLC cells was evident only when p53 was induced in otherwise 
p53 null H1299 NSCLC cells.  Sensitization by  1,25-D3/ EB 1089 was not associated 
with increased DNA damage, decreased DNA repair or an increase in apoptosis, 
necrosis or senescence. Instead sensitization appeared to be a consequence of the 
conversion of the cytoprotective autophagy induced by radiation alone to a novel 
cytostatic form of autophagy by the combination of 1,25-D3 or EB 1089 with radiation. 
While both pharmacological and genetic suppression of autophagy or inhibition of 
AMPK phosphorylation sensitized the NSCLC cells to radiation alone, inhibition of the 
cytostatic autophagy induced by the combination treatment reversed sensitization. 
Evidence for selectivity was provided by lack of radiosensitization in normal human 
bronchial cells and cardiomyocytes. Taken together, these studies have identified a 
unique cytostatic function of autophagy that appears to be mediated by  the vitamin D 
receptor, p53 and possibly AMPK in the promotion of an enhanced response to 
radiation by 1,25-D3 and EB 1089 in NSCLC.  
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Chapter 1 
 
Introduction 
1.1 Cancer: 
The term, “cancer” is derived from Karkinos, which means crab in the Greek 
language. Hippocrates (460-370 BC) coined the term “cancer”, which stands for 
malignant tumors, where cells grow abnormally and are not under the control of 
normal internal and external regulatory mechanisms, (Brucher BL, et al. 2014). 
The oldest known case of metastatic cancer was discovered in a 2,700 year- old 
male skeleton in Siberia, Russia. Not all tumors are cancerous; some can be 
benign, which are not life threatening since they do not invade or metastasize to 
other tissue sites; however these tumors can grow quite large and press on other 
healthy cells, organs and tissues (American Cancer Society, T. 2014d).    
 
Cancer is one of the most common causes of death in the United States as well 
as other parts of the world. One in 4 deaths in the United States is due to cancer. 
As per 2012 statistics, estimated new cases and estimated deaths due to cancer 
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are 1.638,910 and 577,190 respectively (Siegel R, et al. 2012). Efforts at 
eradicating cancer have been ongoing, largely since President Nixon took the 
very first major effort in 1971 by signing the National Cancer Act, with the primary 
objective of strengthening the National Cancer Institute. Since that time billions of 
dollars have been spent on cancer research, data collection and analysis in the 
USA alone.  
 
The most common alterations that occur in cancer are: self-sufficiency in growth 
signals, insensitivity to growth inhibitory signals, sustained angiogenesis, tissue 
invasion and metastasis, evasion of programmed cell death, and limitless 
replicative potential (Hanahan D and Weinberg, 2000). Drug resistance and the 
ability of cancer cells to grow even when one pathway is blocked have made the 
initial treatments such as surgery, chemotherapy, and using radiation alone less 
effective or completely ineffective (Dent P, et al. 2003).  
 
Cancer epidemiology has become an important field of study where researchers 
are working towards gathering information regarding the factors that might 
increase the risk of cancer such as immoderate tobacco use, excessive smoking, 
UV radiation and factors which can help prevent/stop cancer such as healthy 
lifestyle, exercise etc.  These findings are important from a public health point of 
view (American Cancer Society, T. 2014d) and provide insight into the interaction 
of genes at the molecular level with external cancer causing factors (American 
Cancer Society, T. 2014d).  
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It was in the 20th century after DNA was discovered that scientist realized that it 
was damage to the DNA structure by various chemicals or radiation, or 
introduction of a new DNA sequence by viruses, which often were the causes of 
tumor formation.  Under normal circumstances, any significant degree of damage 
to DNA would likely cause normal cell to die or undergo repair; however some 
mutations (in oncogenes and/or tumor suppressor genes, see below) are 
beneficial to the cells in that they do not die but develop into tumor cells that 
continue to grow indefinitely (American Cancer Society, T. 2014d).  
 
1.2 Lung Cancer:  
Lung cancer is the most common cancer in the world and second most 
commonly diagnosed cancer in the United States (Staintigny P, et al. 2012). As 
per statistics, estimated new cases and deaths due to lung cancer in the United 
States in 2014 are expected to be 224,210 and 159,260 (National Cancer 
Institute, T. 2014a; Siegel R, et al. 2012).   
Lung cancer can broadly be divided into Small cell lung cancer (SCLC) and Non-
small cell lung cancer (NSCLC). Small cell lung cancer is identified 
morphologically by its small round nodule shape appearance under the 
microscope.  This type of cancer is more common in the smoking population 
compared to non-smokers and spreads much faster compared to non-small cell 
lung cancer. The best treatment course for small cell lung cancer is usually 
chemotherapy; the most commonly used drugs are cisplatin in combination with 
pacitaxel or gemcitabine and/or radiation if the cancer has spread throughout the 
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body (Johnson DH, et al. 2008). However since 85% of lung cancers are NSCLC, 
which have poor prognosis and are aggressive in nature, we have focused this 
study mainly on sensitization of NSCLC cell lines.  
Non-small cell lung cancer can be divided in to 3 main types (American Cancer 
Society, T. 2014a)- 
A. Squamous cell carcinoma- this type of cancer is also known as epidermoid 
carcinoma and it is the second most common subtype of NSCLC, comprising up 
to 25% of NSCLC cases in the United States. This type of NSCLC usually 
originates in the center of the lung in the bronchi and often stays within the lung, 
spreads to lymph nodes and forms a cavity within the lung. Smoking is one of the 
major causes of this cancer. 
B. Adenocarcinoma – this is the most common type of NSCLC contributing to 
40% of NSCLC cases in the United States. This particular type originates in the 
outer layers of the lung; it develops from the cells lining the air passages and can 
spread to lymph nodes and even beyond. A subtype of adenocarcinoma, 
bronchiolo alveolar carcinoma (BAC), develops at multiple sites in the lungs and 
spreads to preexisting alveolar walls.  
C. Large cell carcinoma- this type of cancer is the least common and accounts 
for only 10-15% of the total NSCLC cases in United States. This type is also 
commonly known as undifferentiated carcinomas.  
Others: 
Bronchial carcinoids: this type accounts for up to 5% of lung cancers. These 
tumors can metastasize and a small proportion of these tumors can secrete 
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hormone like substances. These tumors are usually small, spread and grow 
slowly. This type of cancer can be removed surgically when detected at relatively 
early stages.  
 
1.3 Treatment options:  
Different treatment options available for NSCLC are surgery, chemotherapy, 
radiation, and targeted therapy (American Cancer Society, T. 2014b). These 
treatments are mainly based on tumor histology, extent of advancement (stage), 
and patient specific personal factors (lung functionality, morbidity etc.) 
(Baltayiannis, N. et al. 2013). 
1.3.1 Surgery:  
Surgical therapy remains the keystone in NSCLC treatment in order to offer long-
term survival after a rigorous selection in terms of patients with early stage and 
late more advanced stage cancer. Surgical techniques have progressed 
tremendously in recent years (Baltayiannis, N. et al. 2013). Most stage I and II 
NSCLC are treated with surgery to remove the tumor, usually lobectomy, where 
a lobe or a section of lung containing tumor is removed selectively.  
1.3.2 Chemotherapy:  
After surgical removal of the cancer, patients are usually treated with 
chemotherapy to avoid recurrence; this is known as ‘adjuvant chemotherapy’ and 
is usually done for patients with early cancers. The chemotherapy treatment 
generally involves cisplatin or carboplatin in combination with gemcitabine or 
docetaxel (American Cancer Society, T. 2014b). When these drugs are not 
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effective in the first cycle of treatment, a second round is prescribed, usually with 
a single drug or targeted therapy drug, which is known as second-line 
chemotherapy   
1.3.3 Targeted treatments: These treatments involve using drugs which are 
specific to cancer cells and do not target normal/healthy cells in the surrounding 
tissue (American Cancer Society, T. 2014b). These drugs specifically attach to or 
block targets that are present on the surface of tumor cells. Some of the relatively 
well-established drugs used for targeted therapy in NSCLC are erlotinib, gefitinib, 
which target the tyrosine kinase domain of epidermal growth factor receptor 
(EGFR), and bevacizumab,, which targets vascular endothelial growth factor 
(VEGF) (American Cancer Society, T. 2014b). 
1.3.4 Radiation:  
For patients with advanced stages of lung cancer where surgery cannot be used 
to remove the tumor, high doses of radiation are used in combination with 
chemotherapy. This is usually the case for stage III cancers. At times, receiving 
chemotherapy and/or radiation before surgery can help shrink the tumor and 
make it easier to remove. This is done in order to make the treatment more 
effective (National Cancer Institute, T. 2010a). 
Radiation treatment can be given either externally or internally (American Cancer 
Society; 2014c). External beam radiation therapy uses an external source of 
radiation, which directs radiation to a particular part of the body where the tumor 
is growing whereas the internal method known as brachytherapy involves using a 
radioactive material, which is placed inside the body. The radiation rays from this 
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material can only travel short distances, thereby not harming the surrounding 
normal tissue (National Cancer Institute, 2007a). 
The amount of radiation used in radiation therapy is measured in gray (Gy) units 
and the dose is decided based on the histology, type and stage of lung cancer 
(National Cancer Society 2014a). Typically, 60-70Gy is used for treating non-
small-cell lung cancers and patients receive fractionated doses of 1.8-2Gy five 
times a week over a span of 5-6 weeks (American cancer society, 2014c). 
Fractionated dosing allows the adjoining normal cells to recover from damage in 
case radiation is not very focused (National Cancer Institute T. 2010a). Since 
normal cells generally proliferate more slowly than cancer cells, this provides 
more time to repair the damage (Begg AC, et al. 2011). Patients with inoperable 
locally advanced tumors are the primary candidates for radiation therapy 
(National Cancer Institute, T. 2010a).  
Radiation destroys tumor cells by causing damage to their DNA either directly or 
indirectly by creating charged particles (reactive oxygen species) that leads to 
oxidative stress (Chen DJ and Nirodi CS, 2007). Radiation can cause a number 
of different types of DNA damage such as single-strand breaks, double-strand 
breaks, DNA adducts, and DNA-protein cross-links (Hall and Giaccia, 2004). The 
most lethal lesions produced are double-strand breaks since they cannot be 
repaired as easily by the DNA repair mechanisms (Spitz DR, et al. 2004). Indirect 
DNA damage occurs by the charged particles such as hydroxyl (OH) and O2 
radicals formed by ionization of water (Hall and Giaccia, 2006).  
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Cells can undergo a number of responses to radiation induced DNA damage 
such as cell cycle arrest, senescence, apoptosis, and autophagy (Sun JG, et al. 
2011; Luo H, et al. 2013; Kim KW, et al. 2011; Sancar A, et al. 2004). Depending 
on the type and extent of damage induced by radiation, a number of proteins are 
recruited and activated at the site of damage such as the MRN complex (consists 
of DNA repair proteins; Mre11, Rad50 and Nbs1) that detects double strand 
breaks and the RPA protein (Replication protein A; a heterotrimeric, single-
stranded DNA-binding protein) that detects single strand breaks (Uziel T, et al. 
2003; Flack J, et al. 2005). MRN contributes to recruitment and activation of ATM 
(Ataxia telangiectasia mutated), which is a serine/threonine kinase (Uziel T, et al. 
2003; Flack J, et al. 2005), while RPA recruits ATR (Ataxia telangiectasia related) 
kinase. Once activated, these kinases can further activate effector kinases chk1 
and chk2, which spread the signal further. This leads to a temporary growth 
arrest where cells make an attempt to repair the damage; if the damage is 
repaired, then they cells can reenter the cell cycle and resume proliferation 
(Sancar A, et al. 2004). If the damage cannot be repaired due to compromised 
repair mechanisms or excessive damage then it is thought that cells undergo cell 
death such as apoptosis or necrosis (Elmore S. 2007). 
As with many other therapeutic approaches, radiation also has some limitations. 
Even though initial treatment with radiation is quite effective in destroying tumor 
cells or suppressing their growth, there are factors that lead to development of 
resistance to radiation treatment such as refractoriness to apoptosis in the 
absence of p53 (Zheng R et al. 2014). Recurrence of cancer due to resistance to 
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several treatments such as radiation, chemotherapy, and surgery is one of the 
major issues that need to be addressed in order to attain an effective cancer 
treatment. One of the major issues with non-small cell lung cancer is that it is 
often diagnosed at quite a late stage when tumors have grown large and lie in 
close proximity to normal tissues. Due their close association with the other 
normal tissue, high doses of radiation cannot be used to treat NSCLC. Therefore, 
there is a need to develop strategies to sensitize these tumors to moderate 
doses of radiation. In two of the largest retrospective radiation therapy studies, 
patients with inoperable disease treated with definitive radiation therapy (external 
beam radiation therapy) achieved over all 5-year survival rates of only 10% and 
27% with median survival being 19.5 and 27.9 months respectively (Dosoretz 
DE, et al. 1992; Gauden S, et al. 1995). 
 
 
 
 
 
 
 
 
 
 
 
Ionizing Radiation  
DNA strand break  
Figure 1.1 DNA damage 
induced by radiation. 
Radiation can cause 
damage either directly by 
causing double-strand 
breaks or create charged 
particles and cause 
damage indirectly. 
Dosoretz DE, et al. 1992 
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1.4 Responses to therapies  
1.4.1 Apoptosis (and Necrosis) 
Apoptosis is also known as programmed cell death I. It is an intracellular death 
program that becomes activated when cells are to be eliminated by normal 
biological processes  (Elmore S. 2007). In a typical apoptosis process, a cell 
shrinks, condenses, the nuclear envelope disassembles, the cytoskeleton 
collapses, and DNA breaks up into fragments (Boe R, et al. 1991).  In some 
forms of acute injury leading to sudden death, cells may swell up and burst open 
spilling their cellular contents onto the neighboring cells. This process is called 
necrosis and leads to release of chemotactic signals, which eventually recruit 
inflammatory cells (Elmore S. 2007, Kurosaka K et al. 2003). In apoptosis, 
however, there isn’t any inflammatory reaction.   
 
Intracellular machinery responsible for apoptosis appears to be similar in all 
biological systems. This process uses a class of proteases, called caspases, 
which have a cysteine group at their active site and cleave their target group at 
specific sites, which have aspartic acid (Mcllwain DR, et al. 2013). These 
caspases usually exist in their inactive precursor form known as pro-caspases; 
once activated by aspartic acid cleavage, they further cleave and activate other 
caspases resulting in an amplified cascade process (Mcllwain DR, et al. 2013). 
Pro-caspase activation is triggered by adaptor proteins, which bring multiple 
copies of initiator pro-caspases close together to form an aggregate, which 
undergoes a conformational change to activate procaspase. Once the caspase at 
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the top of the cascade is activated, it cleaves downstream procaspases and 
amplifies the death signal and spread it throughout the cell (Mcllwain DR, et al. 
2013).  
The mechanisms of apoptosis are highly sophisticated and complex, as shown in 
the figure above (Chipuk JE, et al. 2006). The two main pathways are: the 
extrinsic pathway and the intrinsic pathway (Chipuk JE, et al. 2006). Evidence 
suggests that these pathways might be linked and influencing each other (Igney 
FH, et al. 2002). The extrinsic pathway involves activation of death receptors 
after binding to ligands such as FasL, TNF-alpha, Apo3L, and Apo2L (Fesik SW 
2005). These death receptors further activate caspase8, caspase7, capase3 and 
lead to cell death. The Intrinsic pathway involves members of Bcl-2 family 
proteins, which cause mitochondrial outer membrane permeabilization to release 
cytochrome C leading to cell death by activating caspase 3 (Chipuk JE et al. 
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1.4.2. Senescence  
Senescence is a biological phenomenon in which cells lose their ability to divide 
but are still metabolically active. It was first discovered and described more than 
40 years ago by Hayflick and Moorhead who linked cellular senescence to both 
aging and tumor suppression (Hayflick L and Moorhead PS, 1961; Rodier F, et 
al. 2011). Recent literature now suggests that senescence can even contribute to 
normal tissue repair and tumor advancement (Rodier F, et al. 2011). The three 
major identified forms of senescence are:  Oncogene-induced senescence, 
replicative senescence and premature (accelerated or stress induced) 
Figure1.2 Detailed Extrinsic and Intrinsic pathways involved in Apoptosis. The extrinsic 
pathway involves activation of death receptors after binding to ligands such as TNF-alpha and The 
Intrinsic pathway involves members of Bcl-2 family proteins, which cause mitochondrial outer 
membrane permeabilization to release cytochrome C leading to cell death by activating caspase 3  
(Chipuk JE et al. 2006). 
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senescence (Gewirtz et al. 2008).  Oncogene-induced senescence occurs in 
cells in the presence of the expression of oncogenes such as RAS, evidently in 
order to delay transformation (Lee AC, et al. 1999). Expression of V12RAS has 
been linked to increased ROS levels (Lee AC, et al. 1999), which can induce 
DNA damage and result in oxidative modifications of DNA, further leading to up-
regulation of p53 and p21 which induce growth arrest in order to repair the 
damage (Lee AC, et al. 1999). Replicative senescence reflects the ability of cells 
to undergo senescence caused by telomere shortening, which occurs after 
multiple numbers of cell divisions in non-transformed cells (Shay and Robinson, 
2004). Premature, accelerated or stress induced senescence occurs when cells 
undergo stress due to exogenous cytotoxic agents, which usually cause DNA 
damage (Gewirtz, et al. 2008).  
Some of the salient features of senescence include: A) Permanent growth arrest, 
usually irreversible by any known physiological stimuli. However as p16INK4a is 
required to maintain this irreversibility, cells that lack p16 can resume growth 
upon genetic interventions (Beausejour et al. 2003).  B) Induced expression of 
senescence associated beta-galactosidase due to increased lysosomal mass 
(Dimri GP, et al. 1995; Lee BY, et al. 2006). C) Changes in cell morphology. 
Cells increase in size, become larger and more flattened (Hayflick L. 1965). D) 
Increased levels of p16INK4a, which activates the tumor suppressor, Rb, and 
causes an increase in formation of senescence associated hetrochromatin foci 
(SAHF) (Narita M, et al. 2003). SAHF also serves as a marker for identification of 
senescence.  
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Senescence activation is also linked to secretion of senescence associated 
secretory proteins (SASP). The cells release a complex mixture of extra cellular 
matrix, soluble factors and proinflammatory cytokines such as IL6 and IL8  and 
are usually released as a part of an innate immune response responsible for 
tumor clearance (Xue W, et al. 2007).  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Hallmarks of senescence: These hallmarks include expression of SA-Bgal and 
p16INK4a; robust secretion of numerous growth factors, cytokines, proteases, and other proteins 
(SASP); and nuclear foci containing DDR proteins (DNA-SCARS/TIF) or heterochromatin 
(SAHF). (Rodier F and Campisi JJ. Cell Biol; 2011) 
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1.4.3 Radiation-induced cell cycle arrest  
A number of proteins are generally activated when cells sense DNA damage. 
p53 is central to the cells’ response to DNA damage (Cheng G et al. 2013). p53 
is known as ‘guardian of the genome’ and can inhibit tumorigenesis by inducing 
cell cycle arrest to allow for DNA damage to repair (Cheng G, et al. 2013).   
 
Compared to normal cells, cancerous cells can generally divide much more 
rapidly  (Collins K, et al. 1997). The process of cell division usually involves well-
coordinated and orchestrated events that are together known as the cell division 
cycle, as shown in the figure 1.4. Each cell cycle consists of essentially 4 phases; 
S-phase (DNA Synthesis), M-phase (Mitosis), G1-phase (Gap-1), G-2 phase 
(Gap-2). There is an additional phase that cells can enter when they stop cycling 
after division known as the G0 phase, a state of quiescence (Collins K, et al. 
1997). The process of DNA replication and cell division is tightly regulated to 
ensure proper cell growth and prevent replication of damaged DNA (Gogineni 
VR, et al. 2011). A family of CDK-cyclin complexes plays a critical role in keeping 
this process in check. A series of phosphorylation and dephosphorylation events 
regulate the activity of these kinases, ensuring well-defined transitions between 
cell cycle stages (Morgan DO. 1995, Collins K, et al. 1997).  
Various cellular stresses can lead to growth arrest. Cell cycle progression can be 
halted in response to growth factor withdrawal, contact inhibition, and radiation-
induced DNA damage (Gogineni VR, et al. 2011). A set of checkpoint controls 
maintains the orderly nature of cell cycle process. These checkpoints, at the 
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transition between G1/S and G2/M phases, sense any kind of faults in critical 
events such as chromosome segregation and DNA replication (Elledge SJ. 1996; 
Wang J, et al. 2011). Once the checkpoints are activated, they delay the cell 
cycle machinery until the flaw can be fixed or the danger of a mutation has been 
avoided (Elledge SJ. 1996; Wang J, et al. 2011).   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Cell Cycle of eukaryotic cells. Different phases of cell cycle include G1 (Gap 1 
phase), G2 (Gap 2 phase), S (DNA synthesis phase), and M (mitosis phase). Two checkpoints 
are at G1/S and G2/M, which prevent damaged cells from entering synthesis phase and mitosis 
phase. (Dehay C and Kennedy H. Nat Rev Neuroscience 8.  2007) 
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The G1/S checkpoint prevents cells from entering the S-phase by inhibiting 
initiation of replication in the presence of DNA damage (Wang J, et al. 2011). 
Similarly, the G2/M checkpoint prevents cells from undergoing mitosis in the 
presence of damaged DNA (Wang J, et al. 2011). Studies  by Gadbois DM, et al. 
(1996) showed an increase in p53 and p21 levels in cells shortly after radiation 
and suggested that G1 phase delay is dependent on the presence of p53 since 
DNA damage leads to accumulation of p53, which up-regulates the p21/cip-1 
protein; high levels of p21/cip-1 bind to the cyclin/CDK complex and inhibit its 
activity. Since the cyclin/CDK complex is an important coordinator of cell cycle 
progression, its inactivation results in cell cycle delay (Gadbois DM, et al. 1996). 
 
1.4.3 Autophagy  
Autophagy is a catabolic process in which cells break down their own internal 
components to release energy when under different forms of stress. Autophagy 
means  ‘self-eating’.  Autophagy is generally required to maintain basal level 
cellular and tissue homeostasis and is an essential response under conditions of 
stress such as nutrient deprivation, radiation, exercise and infections  (Choi AM, 
et al. 2013a). During stress such as nutrient deprivation, autophagy breaks down 
existing cellular components to produce energy and to degrade organelles being 
damaged by reactive oxygen species production. It also plays an important role 
in the adaptive immune response such as lymphocyte development and antigen 
presentation (Levine B, et al. 2011).   
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A typical autophagy (macroautophagy) process is highly conservative and starts 
with formation of a membrane known as the phagophore or elongation 
membrane, which goes on to entrap various cellular components and organelles 
(Mizushima N. 2007). Autophagosomal elongation is regulated by two ubiquitin-
like conjugation systems, the ATG5-ATG12 pathway and ubiquitin-like protein 
microtubule-associated protein 1 light chain 3 (LC3, ATG8) conjugation system 
(Honscheid P, et al. 2014). After lipidation of LC3II with 
phosphophtidylethanolamine, the autophagosome membrane elongates. 
Complete sequestration of these cellular bodies leads to formation of a double-
membrane vesicle known as the autophagosome.  
 
 
 
Figure 1.5. Different stages of the autophagic process. The process of autophagy starts with 
formation of an isolation membrane, which further elongates to incorporate various cellular 
components and leads to formation of a double membrane structure, autophagosome, which 
further fuses with lysosomes to form autolysome, where degradation of cellular components 
takes place.  (Watson JP and Giuliano V. 2013) 
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Once the autophagosome is formed, it fuses with lysosomes to form 
autolysosomes, where various hydrolase enzymes degrade the cellular 
components and organelles as shown in figure 1.5  (Mizushima N. 2007). 
Autophagolysosomes are single membrane structures since their inner 
membrane has been degraded by lysosomal/ vacuolar hydrolases (Mizushima N. 
2007).  
Different types of autophagy are: Macroautophagy, Microautophagy and 
Chaperone-mediated autophagy (as shown in the figure 1.6) (Honscheid P, et al. 
2014). Macroautophagy (as explained above) is a process where cellular 
components are engulfed in double membrane structures known as 
autophagosomes. So far this is the best-characterized form of autophagy (Kaplan 
K, et al. 2008; Choi AM, et al. 2013a). In contrast to macroautophagy, for 
microautophagy no intermediate vesicles (autophagosomes) are required and 
cellular components are directly engulfed at the lysosomal surface (Honscheid P, 
et al. 2014). In this type of autophagy the lysosomal vacuole membrane either 
invaginates or extends via arm-like protrusions to engulf portions of cytoplasm 
(Uttenweiler A, et al. 2005; Muller O, et al. 2000). In microautophagy, the amino 
acid glutamine is a key nutrient-signaling molecule that signals and activates the 
mTOR pathway that ordinarily maintains inhibition of autophagy. Glutamine 
starvation leads to mTOR inactivation, by localization and activation of 
transcription factors Rtg1p/Rtg3p acting upstream of mTOR (Crespo JL, et al. 
2002). Downstream executers of mTOR involve a number of autophagy related 
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genes and proteins such as ATG5, Beclin-1, ATG7, ATG8, ATG12, which are 
implicated in cell physiology and pathology (Liu B, et al. 2010).   
 
 
 
 
 
 
 
 
 
 
 
In chaperone-mediated autophagy, a cytosolic chaperone protein known as Heat 
shock cognate protein 70 (HSC70), binds to substrates with specific sequences 
and is recognized by lysosomal associated membrane protein 2A (LAMP2A). 
After binding to LAMP2, the protein substrate unfolds and is translocated across 
the lysosomal membrane (Honscheid P, et al. 2014). Similar to microautophagy, 
chaperone mediated autophagy does not involve double membrane 
autophagosome formation. Studies conducted by Wang Y, et al. (2008) with 
murine embryonic fibroblasts (MEFs) from atg5 null mice showed increased 
resistance to mendiaone-induced toxicity (Wang Y, et al. 2008). They further 
indicated that the protection against death from mendiaone was mediated by up-
Figure 1.6. Different types of Autophagy. Three different types of autophagy are 
Macroautoagy, Microautophagy and chaperone-mediated autophagy. (Mizushima N et al. Nature. 
2008) 
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regulation of chaperone-mediated autophagy (CMA), which occurred in atg5-/- 
MEFs in compensation for the loss of macroautophagy (Wang Y, et al. 2008). An 
increase in chaperone-mediated autophagy was indicated by an increase in 
intracellular distribution of LAMP-2A/hsc70 enriched lysosomes (Wang Y, et al. 
2010).  
Autophagic Flux. The processing of the organelles and cellular components 
being degraded once the autophagosome fuses with the lysosome is known as 
autophagic flux. The p62 protein is often used as an autophagic flux marker. p62 
binds to LC3II, is  transported into the autophagosome and is degraded when the 
autolysosome is formed. p62 levels are inversely correlated to autophagy levels.   
 
Autophagy’s contributions to cancer are contradictory. Autophagy can participate 
in the elimination of reactive oxygen species produced by mitochondria and other 
aberrant proteins aggregates, and thereby play an anti-carcinogenesis role 
(Scherz-Shouval R et al. 2007). It is thought that low levels of ROS plays a role in 
cell signaling, but at higher levels, redox active proteins can amplify oxidative 
damage and cause damage to mitochondrial (Ballinger SW, et al. 2000). Scherz-
Shouval R et al. (2007) assessed the role of ROS in autophagy induction by 
using two fluorescent probes dihydroethidum (DHE) and 2’,7’-dichlorofluorescin 
diacetate (DCF-DA). DHE reacts with peroxides and DCF-DA reacts with H2O2 to 
form compounds that upon binding to DNA fluoresce and can be visualized by 
confocal microscopy. Their studies indicate that autophagy is essential for 
removal of defective organelles generating uncontrolled ROS (Scherz-Shouval R, 
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et al. 2007). Additionally, studies done by Kirkland RA, et al. (2002) showed an 
increase in H2O2 and autophagosome accumulation upon starvation. 
Furthermore, NAC (N-acetyl cysteine), which is a ROS scavenger led to a 
decrease in autophagy, implicating ROS signaling as an important regulator of 
autophagy (Kirkland RA, et al. 2002).  
Autophagy can also enhance tumor growth by conferring resistance against 
metabolic stress (Wang RC, et al. 2012). This can be achieved by recycling 
proteins and organelles in already existing tumors. Cell viability studies done by 
Degenhardt K et al. (2006) showed that inhibiting autophagy by silencing Beclin-
1 or atg5 impaired survival in immortalized mouse epithelial cells, consistent with  
the protective nature of autophagy (Degenhardt K et al. 2006).  
 
1.5 Multiple forms/functions of autophagy  
Given the contradictory role(s) of autophagy in cancer development and tumor 
maintenance, before deciding on a potential course of treatment, it is necessary 
to understand what functional role autophagy is playing so that it can be 
exploited for therapeutic advantage. It has been long known that autophagy 
produced in response to radiation/chemotherapy can be protective in nature 
since inhibiting autophagy often leads to increased sensitivity of cancer cells to 
different treatment modalities (Murrow L, et al. 2013; Wilson EN, et al. 2011; 
Bristol ML, et al. 2012). Therefore, it has been anticipated that interfering with 
what appears to be a uniform response to stressors such as radiation and 
chemotherapy could provide a new direction in the enhancement of anticancer 
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treatment (Yang ZJ, et al. 2011; Sui X, et al. 2013). A number of clinical trials are 
ongoing using chloroquine/hydroxychloroquine, which is the only FDA approved 
autophagy inhibitor, in combination with various conventional treatments in order 
to enhance their effectiveness (Sperber K, et al. 1997; Tsakonas E, et al. 2000). 
Although a positive result from these trials would be ideal, there are a number of 
caveats that may have been overlooked before initiating these trials (Gewirtz DA. 
2014). First, it is not possible to predict or determine whether radiation or the 
drugs being used are actually generating the cytoprotective form of autophagy.. 
Second, there is a possibility that autophagy is not a uniform/consistent response 
to radiation and chemotherapy. As described below, there are at least three 
additional forms/functions of autophagy in addition to the protective function. 
However, there is no biochemical or molecular way of distinguishing between 
these different forms of autophagy physiologically or clinically. Third, we do not 
have any reliable clinical marker for identifying and quantifying autophagy 
induction in patients’ tumors. Fourth, given the pharmacokinetics of 
chloroquine/hydroxychloroquine, it is uncertain as to whether these drugs can 
achieve concentrations in tumors sufficient enough to effectively block 
autophagy. Fifth, since it is known that autophagy is required for routine 
elimination of damaged proteins, autophagy deficiency is associated with human 
diseases (Sarkar S. 2013). Any drug that inhibits autophagy in tumors will  likely 
have the same impact on  normal cells as well. Since chloroquine/ 
hydroxychloroquine are given systematically and not specifically to the cancer, it 
is likely to be detrimental to normal tissue homeostasis. 
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Different forms of autophagy that have been identified in our laboratory are as 
follows:  
1.5.1. Cytoprotective autophagy  
As stated earlier, there is no way to differentiate between different functions of 
autophagy based on morphology or the biochemical or molecular impact of the 
different forms. The protective function is defined empirically essentially because 
blocking it either by using pharmacological inhibitors or genetic silencing leads to 
increased sensitivity of tumors to the autophagy-inducing stress, such as 
radiation (Murrow L, et al. 2013; Wilson EN, et al. 2011; Bristol ML, et al. 2012). 
Most commonly, this sensitization is via promotion of apoptosis Elmore S, 2007; 
Ko A, et al. 2014).  However, it is important to show that blocking autophagy 
actually leads to sensitization by performing clonogenic survival or cell viability 
studies. The idea of cytoprotective autophagy is based on the premise that 
induction of autophagy confers resistance to the inducing agent and that 
inhibiting this form would enhance treatment response. However, selectivity still 
remains a problem with using autophagy inhibitors. Since defective autophagy is 
associated with a number of neurodegenerative diseases such as Alzheimer’s 
disease and Parkinson’s disease (Sarkar S. 2013), autophagy inhibition in 
normal cells can be detrimental. Furthermore, drugs and treatments that lead to 
induction of protective autophagy in tumor cells would do the same even in 
normal cells causing an increased drug toxicity when autophagy is inhibited. This 
issue of cell toxicity could be short term in situations where autophagy inhibition 
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occurs for a very brief time period and normal cells can recover faster than the 
tumor cells.  
In a seminal study performed by the Kroemer group, the putative cytotoxic 
function of autophagy for conventional antitumor drugs was largely put to rest 
(Shen S, et al. 2011). Their studies demonstrated that inhibiting autophagy by 
knocking down ATG7 did not result in any protection from their anti-proliferative 
or cytotoxic actions. This finding if extrapolated to clinics, would support the 
potential utility of autophagy inhibition as a therapeutic strategy if, in fact, 
conventional drugs promote solely cytoprotective autophagy.   
 
1.5.2. Non-protective autophagy  
In this form, a number of stress inducers promote autophagy, but inhibiting 
autophagy does not alter sensitivity to the stressor. Studies performed in our 
laboratory have shown that in breast tumor cells (Hs578t) (Chakradeo S, et al.- in 
preparation) and murine breast tumor cells (4T1s) (Bristol ML, et al. 2013), 
inhibiting autophagy with chloroquine did not alter sensitivity of tumor cells to 
radiation. One of the possible explanations for lack of sensitization altering 
effects in vivo (Bristol ML et al, 2013) could be related to Kroemer’s findings 
about how autophagy inhibition interferes with the immune system’s capability to 
recognize tumors undergoing a stress response (Michaud M, et al. 2011; Ko A et 
al. 2014). These studies indicate that besides other concerns, it is imperative to 
determine that a particular treatment is generating cytoprotective form of 
autophagy before considering making efforts to inhibit it as a treatment strategy.  
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1.5.3. Cytotoxic autophagy 
Previous studies from our laboratory have shown that vitamin D and its analogs 
when used in combination with IR are able to promote autophagy that is cytotoxic 
in nature (Bristol ML, et al. 2012; Wilson EN, et al. 2012). Other laboratories have 
also reported generation of a cytotoxic form of autophagy by either killing the 
cells itself or by acting as a precursor to apoptosis (Sui X, et al. 2013). In the 
cytotoxic form of autophagy, there is a reduction in viable cell number as well as 
a reduction in clonogenic survival upon treatment. However, fundamentally it is 
differentiated from the cytoprotective autophagy in that when cytoprotective 
autophagy is inhibited, cells are sensitized to the treatment modality whereas 
when cytotoxic autophagy is inhibited, cells become less sensitive to the 
treatment.  
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Figure 1.7 Different functions of autophagy induced in response to different stresses and 
cell type. Non-protective autophagy; does not seem to contribute to cell death or survival. 
Cytoprotective autophagy; it contributes to cell survival. Cytotoxic autophagy; induces cell death in 
response to the treatment.  
 
 
 
Figure 1.8 Comprehension of different functions of autophagy upon autophagy inhibition. 
Cytotoxic/cytostatic function; autophagy inhibition leads to a reversal in sensitization. Non-
protective autophagy; Inhibition of autophagy does not alter sensitization. Cytoprotective 
autophagy; Inhibition of autophagy sensitizes the cells to treatment. 
 
 
 
 
/Cytostatic  
IR induced autophagy  
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1.6 Signaling pathways associated with autophagy  
 
1.6.1 AMPK/ULK-1 pathway 
AMPK, a widely recognized sensor of cellular energy status, phosphorylates a 
number of target proteins with energy metabolism related functions in response 
to an ATP-depleted adenine nucleotide pool (Roach PJ. 2011). A number of 
studies have linked activation of AMPK to increased autophagic activity (Samari 
HR, et al. 1998; Wang Z, et al. 2001). Typically, AMPK exists as a heterodimer 
consisting of  one catalytic subunit, α, and two regulatory subunits, β and γ. 
When intracellular levels of ATP are low, ADP or AMP can bind directly to γ 
subunits, which leads to a conformational change that causes phosphorylation of 
the catalytic subunit, α, leading to activation of AMPK (Xiao B, et al. 2011; Oakhill 
JS, et al. 2011). Another possibility by which AMPK can be activated is direct 
phosphorylation at Thr 172 by a serine/threonine kinase LKB1, which is a tumor 
suppressor gene (Hawley SA, et al. 2003; Woods A, et al. 2003; Shaw RJ, et al. 
2004). AMPK can also be activated by phosphorylation at Thr172 by CAMKKβ in 
response to alterations in calcium flux (Hurley RL, et al. 2005; Woods A, et al. 
2005; Fogarty S, et al. 2010). Interestingly, some studies further indicate 
activation of AMPK by the tumor suppressor gene, p53 (Alexander A et al. 2011; 
Feng Z et al. 2005). 
 
In response to nutrient starvation, AMPK acts as a regulator of cell growth. One 
of the best-described mechanism by which it modulates cell growth is by 
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inhibiting the mammalian target of rapamycin complex 1 (mTORC1) pathway 
(Mihaylova MM, et al. 2011).  Studies have linked AMPK to mTORC1 control by 
two separate pathways (Wullschleger S, et al. 2006). One, AMPK inhibits 
mTORC1 by phosphorylating TSC2 and deactivating Rheb GTPase (Inoki K, et 
al. 2003) and second, phosphorylation of Raptor component of mTORC1 with 
subsequent recruitment of 14-3-3 proteins lead to inhibition of mTOR activity 
(Gwinn DM, et al. 2008).   
Among various components, which regulate autophagy, mTORC1, which is a 
serine/threonine protein kinase, remains an important component that regulates 
the balance between growth and autophagy in response to environmental and 
physiological stress (Jung CH, et al. 2010). mTORC1 acts as a sensor of cellular 
nutritional starvation, stress and growth factor signaling. mTORC1 activity is 
inhibited under nutrient deprivation, which leads to autophagy induction in 
eukaryotes (Noda T, et al. 1998; Scott RC, et al. 2004). mTORC1 has a broad 
range of cellular functions; it is involved in regulation of translation, transcription 
and metabolism in response to growth factors in yeast and higher eukaryotes 
(Jung CH, et al. 2010). This further makes this protein kinase an important 
element to study for cancer, neurodegenerative diseases, metabolism and aging 
(Jung CH, et al. 2010).  
In order to fully understand how mTORC1 is able to regulate the autophagy 
machinery, it is important to study mechanisms downstream of mTORC1. In 
yeast, Atg1 is the first signaling component downstream of mTORC1 in the 
autophagy pathway, which plays a key role in the initiation stages of autophagy 
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such as nucleation and formation of preautophagosome structures (PAS) (Noda 
T, et al. 1998; Straub M, et al. 1997; Matsuura A, et al. 1997). Interaction of Atg1 
with other autophagy proteins such as Atg13, Atg17, Atg29, and Atg31 depends 
on the nutrient status and mTORC1 activity (Kamada Y, et al. 2000; Funakoshi T, 
et al. 1997; Kawamata T, et al. 2008; Kabeya Y, et al. 2009, 2005). mTORC1 
inhibits autophagy by phosphorylating Atg13 at multiple sites to prevent its 
binding to Atg1. However, under starvation mTORC1 is inactivated and 
phosphorylation of Atg13 is suppressed. This then results in binding of Atg1 to 
Atg13 and other essential autophagy proteins to induce autophagy.  
The counterpart of Atg1 in mammalian cells is ULK (unc-51 like kinase). As per 
recent literature, interaction of ULK1and ULK2 with the mammalian homologue of 
Atg13 plays an essential role autophagosome formation (Jung CH, et al. 2003; 
Chan EY, et al. 2009; Chang YY, et al. 2009; Ganley IG, et al. 2009; Hosokawa 
N, et al. 2009a,b). Other proteins such as Atg101 and FIP200 (focal adhesion 
kinase family interacting protein) interact with ULK1 and to promote 
autophagosome formation in mammals (Hara T, et al. 2008; Mercer CA, et al. 
2009; Hosokawa N, et al. 2009). mTORC has been shown to regulate kinase 
activities of ULK1 and ULK2 (Hara T, et al. 2008; Jung CH, et al. 2003; Ganley 
IG, et al. 2009; Hosokawa N, et al. 2009). Conditions such as leucine deprivation 
or rapamycin treatment, which lead to inhibition of mTORC1, have been shown 
to enhance kinase activities of ULK1/2 and trigger phosphorylation of Atg13 and 
FIP200 (Jung C, et al. 2003, Ganley IG, et al. 2009, Hosokawa N, et al. 2009). 
Current literature suggests that the Atg1/ULK and mTORC1 complexes play a 
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key role in the pathways that regulate growth and autophagy in response to 
various pathophysiological and nutritional conditions. Atg1/ULK negatively 
regulate mTORC and growth to ensure favorable conditions for autophagy 
induction. Recent studies further link AMPK and ULK1 in mammalian cells (Egan 
DF, et al. 2011; Kim J, et al. 2011; Lee JW, et al. 2010).  These studies indicate 
that nutritional deprivation activates mammalian AMPK, which further leads to 
phosphorylation and activation of ULK-1 (Roach PJ. 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 Role of AMP-activated protein kinase in the control of autophagy. AMPK 
when activated leads to induction of autophagy either by activating ULK-1 or b inhibiting 
mTOR. Roach PJ. 2011 
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1.6.2 p53 and its role in autophagy  
The p53 tumor suppressor gene is known to induce senescence and apoptosis 
(Levine AJ et al. 2006). Its pro-apoptotic function is carried out at two levels; one 
is through activating pro-apoptotic proteins such as Noxa, Bax and Puma and the 
other one is independent of its nuclear function where its physical interaction with 
multi-domain members of the Bcl-2 family at mitochondria leads to mitochondrial 
membrane permeabilization (Zong WX, et al. 2008). The pro-senescence 
function of p53 is mediated by activating cell cycle inhibitors (Zong WX, et al. 
2008). Recent literature suggests that in addition to its tumor suppressor 
function, p53 is also involved in regulation of autophagy (Zong WX, et al. 2008; 
Levine B, et al. 2008).  
One possible mechanism for autophagy initiated by p53 could be activation of 
AMPK kinase, which subsequently activates TSC1 and TSC2 kinases to cause 
mTOR inhibition (Inoki K, et al. 2003)). Another possibility is activation of DRAM 
(damage-regulated autophagy modulator), which is a lysosomal protein and a 
target of p53 (Zhang XD, et al. 2013). Studies conducted by Zhang XD et al. 
further established DRAM1’s role in regulation of autophagic flux by using A549 
cells, which have wild-type TP53.  An increase in autophagic flux was observed 
on using a mitochondrial inhibitor, 3-nitropropionic acid (3-NP), indicated by an 
increase in protein levels of DRAM1 and LC3II and a decrease in p62 protein. 
Furthermore, knockdown of TP53 in cells impaired DRAM induction, indicating 
TP53’s involvement in DRAM mediated autophagy (Zhang XD, et al. 2013).  
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p53 appears to be capable of playing a dual role and has autophagy inhibiting 
and/or inducing functions (Zong WX, et al. 2008; Tasdemir E, et al. 2008a,b; 
Morselli E, et al. 2008).  An increase in DNA damage, chromosomal instability 
and deregulated control of cell growth is caused by loss of autophagy genes, 
indicating a potential overlap in p53 actions and tumor suppressor-related 
autophagy effects (Levine B, et al. 2008). When cells are exposed to genotoxic 
stress, activation of p53 leads to stimulation of autophagy (Feng Z, et al. 2005; 
Zeng X, et al. 2007; Abida WM, et al. 2008). In contrast, p53 loss induces 
autophagy in the absence of stress, suggesting that basal levels of p53 activity 
could be inhibiting autophagy (Tasdemir E, et al. 2008a). Tasdemir et al. 
performed studies using HCT116 cells and used TEM to indicate increases in 
autophagy upon inhibition of p53 using both genetic and pharmacological 
inhibition appprocahes (Tasdemir E, et al 2008a). p53 seems to be playing a 
central role in the process of autophagy, such that both its activation and 
suppression can lead to autophagy in response to wide variety of cell damage 
signals (Zong WX, et al. 2008).   
The precise role of p53 has been suggested to be dependent on its localization 
within the cell (Chaachouay H, et al. 2011). ATM signaling in the nucleus 
appears to play an important role in radiation-induced autophagy. Nuclear p53 
undergoes post-translational activation by ATM following exposure to IR (Pan J 
et al. 2009). Once activated, p53 can transactivate a number of genes that 
upregulate autophagy (Alexander A, et al. 2010; Feng Z et al. 2005). To 
understand how p53 inhibits autophagy, Tasdemir E, et al. (2008a) compared the 
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transcriptome of wild type and p53-/- HCT116 cells but failed to find any changes 
in autophagy-related transcripts suggesting that p53 suppression of autophagy 
could be transcription independent (Tasdemir E, et al. 2008a). To investigate this 
further, HeLa cytoplast (enucleated cells) were used, which in response to PFT-a 
(p53 inhibitor) still led to an increase in GFP-LC3 puncta, indicating that nuclei 
were not required for PFT-a-stimulated autophagy (Tasdemir E, et al. 2008a). To 
understand the mechanism by which p53 inhibits autophagy further experiments 
were conducted using p53-/- HCT116 cells, which were transfected with p53 
targeted to either nuclear or extra-nuclear locations. Both wild-type and 
endothelium reticulum (ER)-targeted p53 led to the inhibition of autophagy as 
compared to the p53 form locked into the nucleus (trapped in the nucleus using a 
disrupted nuclear export signal) as indicated by GFP-LC3 immunofluorescence 
staining (Tasdemir E, et al. 2008a). These studies suggest that cytoplasmic, not 
nuclear, p53 is required for inhibition of autophagy.  
Given the numerous roles that p53 can play and the processes in which it is 
involved, genome wide studies have been conducted to study its transcriptional 
responses. An early study in 2006 by Wei et al. made use of chromatin 
immunoprecipitation (ChIP) paired end ditag (ChIP-PET) technology and defined 
a number of novel p53 target genes whose expression levels and functions 
correlated with clinical outcomes in  cancer patients (Wei CL, et al. 2006). Since 
then a number of studies using ChIP technology have been used to gain novel 
insights into p53 biology (Lee KH, et al. 2010; Li M, et al. 2012). Recently a study 
conducted by Broz et al. identified a host of autophagy genes that are being 
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induced by p53 and its family members p63, p73. Their studies suggested that 
autophagy network activation is a fundamental element of p53 biological function 
(Kenzelmann Broz D, et al. 2013) and highlighted the importance of the 
transcriptional activity of p53 for the induction of autophagy. Furthermore, they 
indicated that deficiency/inhibition of autophagy did not alter DNA damage-
induced cell cycle arrest and/or survival but induced p53-dependent apoptosis. 
However, the question of how exactly autophagy contributes to p53 dependent 
apoptosis is still not answerable (Kenzelmann Broz D, et al. 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. Proposed model for autophagy signaling pathway in response to radiation in 
NSCLC. Genotoxic stress (such as IR+EB 1089) leads to stabilization and activation p53, which 
leads to activation/phosphorylation of AMPK. AMPK further induces autophagy by either 
activation of ULK-1 or inhibition of mTOR.  
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1.7. Vitamin D  
Vitamin D is a hormone known for its role in calcium and phosphorus 
homeostasis. The majority of vitamin D is synthesized in the body by exposure to 
sunlight (Norton R, et al. 2012). Moderate amounts can also be obtained from 
diet such as fish, and fish-oils (Norton R, et al. 2012). Cholecalciferol, a precursor 
of vitamin D3, is obtained by UVB radiation’s action on 7-dehydrocholesterol in 
the skin (Norton R, et al. 2012). Vitamin D precursors are then taken to the liver 
by vitamin D binding proteins (VDBP), where they are hydroxylated to be 
converted to 25-dihydroxyvitamin D (25(OH)D or calcidiol). 25(OH)D is the form 
in which vitamin D circulates in the body and is used as a measurement of 
vitamin D status in an individual (Norton R, et al. 2012). 25(OH)D is further 
hydroxylated by the cytochrome 1a-hydroxylase enzyme CYP27B1 in the 
kidneys to produce the most potent and biologically active form 1,25-
dihydroxyvitamin D (1,25(OH)2 D or calcitriol), which has a half-life of 15hr 
(Radermacher J, et al. 2006; Hansdottir S, et al.  2008; Shaffer PL, et al. 2002). 
Another cytochrome 24-hydroxylase CYP24A1 enzyme further metabolizes both 
25(OH)D and 1,25(OH)2D to 24,25-dihydroxycholecalciferol (24,25(OH)2D) to 
keep vitamin D concentrations in blood strictly regulated (Holick MF et al. 2007). 
1,25(OH)2D3, the active form of vitamin D is able to mediate its effect only after 
binding to the vitamin D receptor (VDR) (DeLuca HF. 2004).  
 
The human VDR protein consists of 427 amino acids and has a DNA-binding 
domain, a ligand binding domain and an activating domain (DeLuca HF. 2004). 
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1,25(OH)2D3 binds to the ligand binding domain located at the carboxyl terminus 
of the VDR protein. This binding changes VDR’s conformation, allowing 
interaction with transcription factors (Shaffer PL, et al. 2002). Once activated, 
VDR binds to retinoic acid X receptor and forms a heterodimer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This heterodimer then translocates to the nucleus, where it binds to the vitamin D 
response elements in the promoter region of target genes (Nagpal S, et al. 
2005). Therefore, most of the effects of vitamin D are VDR dependent (Holick 
Figure 1.11. Vitamin D metabolism. Vitamin D obtained from either diet or sun, has to 
undergo two hydroxylations to be converted into its active form, 1,25(OH)2D3. (Deeb KK 
et al. Nature Reviews Cancer 7. 2007) 
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MF. 2007). However, studies have indicated that vitamin D can also have some 
rapid non-genomic effects such as rapid regulation of membrane calcium 
channels in cultured chick skeletal muscle cells (Vazquesz G, et al. 1997). These 
rapid responses are mediated by a new receptor known as 1,25-D3-membrane-
associated-rapid-response-steroid-binding-protein-receptor (1,25MARRS) 
(Nemere I, et al. 1998,2004). Studies in MCF-7 breast tumor cells indicate that 
the presence of this receptor interferes with the anti-proliferative effects of 
1,25(OH)2D3 (Richard CL, et al. 2010; Wu W, et al. 2010). Further investigation 
needs to be done to determine the exact role of this receptor in anti-proliferative 
effects of 1,25(OH)2D3.  
 
1.7.1 Vitamin D and autophagy  
Vitamin D leads to increased intestinal calcium absorption by activating VDR 
(Song Y, et al. 2003). ER releases this calcium, which activates calcium-
dependent kinases and phosphatases and leads to activation of various cellular 
processes, including autophagy (Hoyer-Hansen, et al. 2007). Some of the 
signaling pathways that vitamin D3 regulates include Beclin-1, mammalian target 
of rapamycin (mTOR), the class III phosphatidylinositol 3-kinase complex 
(PI3KC3) and Bcl-2 pathways. (Wu S, et al. 2011; Van Leeuwen and Pols, 2005). 
mTOR expression can be down-regulated by vitamin D3, thus leading to an 
induction in autophagy (Loewith R, et al. 2002; Wang J, et al. 2008).  
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Beclin-1 is one of the key elements of the PI3KC3 complex (Kang R, et al. 2011) 
and sits at the core of autophagy regulation (Sun et al 2009). The PI3KC3 
complex is important for localization of autophagic proteins at the pre-
autophagosomal structure (Kang R, et al. 2011; Kihara A, et al. 2001). Beclin-1 is 
regulated by a number of factors including Bcl-2 (Pattingre S, et al. 2005), 
vitamin D3 and vitamin D analogs (Hoyer-Hansen et al. 2005; Wang J, et al. 
2008). However, the mechanism vitamin D uses to increase Beclin-1 expression 
still isn’t clear. One possible mechanism could be through Bcl-2 since Bcl-2 binds 
directly to beclin-1 at a BH3 domain inhibiting beclin-1 and consequently 
autophagy (Sinha S, and Levine B. 2008). Ylikomi et al. (2002) conducted 
studies to show that 1,25-D3 downregulates expressions of Bcl-2 in MCF7 breast 
tumor cells and HL-60 leukemia cells (Ylikomi T et al. 2002). Studies have also 
shown that starvation induced autophagy levels can be increased by 
endogenous silencing of Bcl-2, which would possibly lead to an increase in 
availability of beclin-1 to be recruited to bind to PI3KC3 (Maiuri MC, et al. 2006; 
Pattingre S, et al. 2005; Zhang XD, et al. 2009).  
 
1.7.2 Vitamin D and cancer:  
Vitamin D has been shown to have anti-tumorigenic effects both in-vitro and in-
vivo  (Norton R, et al. 2012). A decrease in circulating levels of 25-
hydroxyvitamin D (25(OH)D), the circulating precursor of calcitriol, has been 
shown to be associated with increased risk of cancer (Giovannucci E. 2008, 
Krishnan AV, et al. 2010). Vitamin D has been shown to induce apoptosis in 
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breast and colon cancers but can have some differential effects such as growth 
arrest in G1-S phase as suggested by studies in prostate cancer (James CF, et 
al. 2008). Some of the other anticancer related properties of vitamin D include its 
antimetastatic, anti-inflammatory and antiangiogenic effects (Vanoirbeek E, et al. 
2011).  
 
Vitamin D has been indicated to regulate signaling pathways which impact 
cellular growth and differentiation via proteins such as Ras and MAPK, cyclic 
AMP, protein kinase A, protein lipase A, prostaglandins, and phosphatidyl inositol 
3 kinase (Deeb KK, et al. 2007). It is also proposed to induce cyclin dependent 
kinase (CDK) inhibitors or inhibite cyclin D/cdk4-6, which would lead to reduced 
activity of the E2F transcription factor by causing hypophosphorylation of Rb 
(Eelen G, et al. 2004). A recent study by Zhou et al. showed that there is a close 
association between improved survival in early stage lung cancer and high 
1,25(OH)2D3 circulating levels (Zhou W, et al. 2005, 2007). Various preclinical 
studies have demonstrated anti-proliferative effects of vitamin D. Inhibition of 
tumor growth and metastases by 1,25(OH)2D3 has been shown in mouse models 
(Young MR, et al. 1995).  
 
Vitamin D has been used in combination with other treatments in lung cancer. 
Studies by Zhuravel E, et al. (2010) showed that using vitamin D in combination 
with an experimental cancer vaccine in the Lewis Lung Cancer model led to a 
significant increase in the anti-metastatic effect of the vaccination. The drug by 
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itself was not potent enough to cause any reduction in tumor volume and 
metastasis (Zhuravel E, et al. 2010). Furthermore using vitamin D analogues, 
PRI-2202 and PRI-2205 in combination with cisplatin was more effective 
compared to cisplatin alone (Wietrzyk J, et al. 2007).  Studies using chemical- 
induced mouse models of lung cancer in Balb/c mice which developed tumors 
when treated with urethane show a pronounced decrease in tumor formation 
when given vitamin D in their diet (Koohdani F, et al. 2008). All of these studies 
support the idea of vitamin D’s possible role in lung cancer therapy.  
 
1.8. Previous studies 
One of the primary goals of our laboratory has been to identify and develop 
strategies to enhance sensitization to radiation. One such approach is to employ 
vitamin D and vitamin D analogues, which are known to have anti-tumorigenic 
effects, in combination with radiation. Tumor recurrence is one of the major 
problems that lead to inefficient treatment, since the recurred tumor is more 
resistant to the treatment. Our laboratory has reported on studies using vitamin D 
analogues, EB 1089 (seocalcitol) and ILX23-7553, in combination with 
Doxorubicin (Topoisomerase II poison) and radiation (Gewirtz, DA et al. 2000; 
Sundaram S, et al. 1999; Sundaram S, et al. 2003). 
Previous data generated by our lab has shown that active form of vitamin D, 
1,25-D3 and the vitamin D analogue EB 1089 produce a significant reduction in 
growth of MCF7 breast tumor cells when used in combination with radiation or 
Doxorubicin (Chaudhry M, et al. 2001, Demasters et al. 2006, 2004; Sundaram 
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S, et al. 1999, 2003). In vivo studies conducted using EB 1089 and MCF7 breast 
tumor xenografts in nude mice also indicated enhancement of radiation effects 
(Sundaram S, et al. 2003). These studies also indicated that EB1089 in 
combination with IR or Doxorubicin failed to generate significant amounts of 
apoptosis and mitotic catastrophe, which were initially thought to be the 
mechanism of sensitization (Demasters et al. 2006, 2004). Studies conducted in 
order to determine the mode of this radio sensitization by vitamin D indicated that 
autophagy could be the mode of this sensitization since there was a significant 
increase in autophagy with the combination treatment of IR and vitamin D 
(Demasters et al. 2006).  
While our laboratory has previously established that vitamin D and its active 
analogues such as EB 1089 are capable of radio-sensitizing breast tumor cells, 
the current studies were designed to build upon and expand the sensitization 
studies to Non-small cell lung cancer cell models, as non-small cell lung cancer 
is considered to less responsive and less susceptible to the effects of radiation 
compared to breast cancer. Breast cancer is much more amenable and 
responsive to treatment, for a couple of reasons. One is that it is generally 
detected early in its progress through screening or self-examination and 
therefore can be resected surgically and/or irradiated. Furthermore, there are 
many chemotherapeutic strategies that are effective, both in terms of 
conventional drugs (paclitaxel, cyclophosphamide, doxorubicin) as well as 
adjunctive therapies (herceptin) and hormonal therapies (tamoxifen and 
aromatase inhibitors) (American Cancer Society, T. 2012). One of the major 
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issues with treatment of NSCLC is late diagnosis; consequently the tumors are 
generally quite large and lie in close proximity to  normal tissues,  making it 
difficult to either resect or treat with high doses of radiation. Therefore, there is a 
need to sensitize these tumor cells to moderate doses of radiation. We also 
assessed levels of the vitamin D receptor in different non-small cell lung cancer 
cell lines and found that most of the cell lines that we tested express high to 
moderate levels of VDR, which further indicated that they are likely to respond to 
the combination treatment since vitamin D mediates its actions through VDR.  
Our studies were designed to test the following hypotheses:   
 
• 1,25-D3 and EB 1089 will radiosensitize relatively radio-resistant A549 
and H460 lung tumor cells.  
• Promotion of autophagy will prove to be responsible for the radio-
sensitization  
• The AMPK/ ULK-1 pathway will play a role in the radio-sensitization of 
NSCLC cells by 1,25-D3 and EB 1089.  
 
To test our hypotheses we developed the following aims: 
Specific Aim 1: To establish the capacity of 1,25-D3 and EB 1089 to radio-
sensitizes NSCLC cells using A549 and H460 cells.  
Specific Aim 2: To substantiate that autophagy is the mode of radio-
sensitization in NSCLC cells treated with 1,25-D3 or EB 1089 using both 
pharmacological and genetic inhibition tools 
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Specific Aim 3: To determine the signaling pathways that might be involved in 
1,25-D3 /EB 1089 mediated radio-sensitization. 
 
1.9. Cytostatic autophagy 
A novel form/function of autophagy has been identified in our laboratory that is 
the focus of this thesis.   Studies in non-small cell lung cancer cells exposed to 
vitamin D or a vitamin D analog in combination with radiation have identified a  
“cytostatic” function of autophagy. As with the other forms of autophagy, the 
definition of this form is  entirely functional and empirical. The combination of 
vitamin D and radiation is able to induce much more pronounced inhibition in 
growth of NSCLC cells compared to radiation alone, which is indicative of 
increased sensitization. Similar to the cytotoxic effect, when this cytostatic form 
of autophagy is inhibited, we see a reversal in sensitization; what differentiates 
cytostatic from cytotoxic autophagy is the lack of cell killing with the cytostatic 
form, as shown by cell viability/clonogenic survival studies done with breast 
tumor cells (Bristol ML, et al. 2012; Wilson EN, et al. 2011) previously and non-
small cell lung cancer cells in this study. The treatment conditions were the same 
for both tumor models.  
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Figure 1.12 A novel function, cytostatic, identified in NSCLC cells.  In addition to 
three other forms defined earlier, a novel form of utophagy has been identified in 
NSCLC cells; this function induces growth arrest in response to treatment and reverses 
sensitization when inhibited.  
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Forms of Autophagy  Characteristics 
Cytoprotective  
• Induced in p53 wild-type 
tumor cell lines in response 
to radiation treatment; 
A549, H460, MCF7, Zr75) 
a. May confer resistance to therapy 
b. Increased sensitivity to therapy 
when blocked  
c. Increased apoptosis when blocked 
d. Possibly involved in normal tissue 
homeostasis 
Cytotoxic  
• Induced mainly in response 
to the combination 
treatment of radiation and 
vitamin D in p53 wild-type 
breast tumor cell lines; 
MCF7, Zr75) 
a. Promotes cell death when induced 
b. Cell death could be associated 
with apoptosis 
c. Reversal in sensitization when 
blocked 
 
Cytostatic  
• Induced in response to the 
combination treatment of 
radiation and vitamin D in 
p53 wilt-type non-small cell 
lung cancer cell lines; 
H460, H1299 (inducible 
p53)) 
a. Mediates growth inhibition  
b. Results in reduced clonogenic 
survival  
c. Potentially associated with 
senescence/growth arrest 
d. Could be involved in tumor growth 
delay /dormancy 
Nonprotective 
• Induced in response to 
radiation treatment in p53 
null or mutant tumor cell 
lines; H1299 (p53 null 
NSCLC), Hs578t (p53 
mutant breast tumor cell 
line).  
a. No difference in intensity when 
compared to other forms 
b. No physiological differences when 
compared to others 
c. Inhibition does not influence or 
alter the sensitivity to therapy 
d. Relevance not quite understood  
 
 
 
 
 
 
Table 1:  Summary of the characteristics of different functions /forms of autophagy.  
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Historically, from our understanding the primary function of autophagy occurring 
under nutrient deprivation has been to allow cell survival in a state of stasis 
where the metabolic state is maintained, which is essentially what we see with 
the cytostatic autophagy (Levine B. 2007; Gewirtz DA. 2014).  However, it must 
also be emphasized that this cytostatic form is clearly different from the 
cytoprotective form. In the same cells where we as well as Kroemer’s group have 
demonstrated cytoprotective function of autophagy in response to radiation alone 
(Ko A et al. 2013), addition of vitamin D or EB1089 converts this cytoprotective 
function into cytostatic autophagy.  
 
However, the therapeutic implications of cytostatic autophagy would be similar to 
that of the cytotoxic form. That is, if chemotherapeutic agents or radiation are 
promoting prolonged cell growth arrest, then suppression of autophagy is likely to 
reduce the impact and effectiveness of the therapy. 
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Chapter 2 
 
Materials and Methods: 
2.1 Cell lines:  
The p53 wild-type (WT) A549, VDR null H838, and p53 mutant H358 human non-small 
cell lung tumor cell lines along with normal human bronchial epithelial cell line HBEC3-
KT originally generated by the Minna laboratory (Sato M, et al. 2006) were generously 
provided by Dr. Charles Chalfant at Virginia Commonwealth University. H460 (wild-type 
p53), human non-small cell lung cancer cell line, was a generous gift from Dr. Richard 
Moran at Virginia Commonwealth University. H460 shBeclin-1, shAtg5, shcontrol cells 
were generated as described below.  H1299 null and p53 inducible human non-small 
cell lung cancer cells were originally developed by Dr. Constantinos Koumenis 
(Maecker HL, et al. 2000) and provided by our collaborators, Drs. Frank and Suzy Torti, 
at the University of Connecticut. 
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Mission shRNA bacterial stocks for Atg5 and Beclin-1 were purchased from Sigma 
Aldrich (St. Louis, MO, #TRCN00151963 and #TRCN0000299864, respectively). 
Lentiviruses were produced in HEK 293TN cells co-transfected using Lipofectamine 
(Invitrogen, Carlsbad, CA) with psPAX2 and pMD2.G packaging constructs (Addgene, 
Cambridge, MA ). Viruses shed into the media were then used to infect H460 cells. 
Puromycin (1µg/ml) was used as the selection marker to enrich the infected cells.  
 
2.2 Cell culture and treatment:  
H460, A549, and H1299 cells were maintained in DMEM media supplemented with 10% 
(v/v) FBS, 100 U/ml penicillin G sodium and 100µg/ml streptomycin sulfate. H838 cells 
were maintained in RPMI 1640 media supplemented with the same amounts of serum 
as mentioned above. HBEC3-KT cells were maintained in Keratinocyte-SFM media 
supplemented with FBS (given with the kit), 100 U/ml penicillin G sodium, and 100µg/ml 
streptomycin sulfate. H460 shAtg5 and shBeclin-1 cells were maintained with puromycin 
(1µg/ml) for selection. All cells were maintained at 37°C under a humidified, 5% CO2 
atmosphere, except otherwise indicated. After equilibration post seeding, cells were 
treated with single dose of 6Gy radiation alone (using a 137Cs irradiator), 100nM 1,25-D3 
alone, or 100nM EB1089 (Tocris Bioscience, Bristol, UK) alone, or the combination of 
1,25-D3 or EB 1089 with 6Gy radiation dose.  Cells were washed free of the 1,25-D3 or 
EB 1089 after 48 hours (i.e. exposure for 24 hours prior to and 24 hours post 
irradiation). 
 
 
 
50 
2.3 Cell viability and Clonogenic survival:  
Cell viability was assessed by trypan blue exclusion at various time points after the 
treatment. Trypan blue is a live-dead cell dye, which can enter the cells and stain them 
blue when they are dead and their membrane is compromised. 10,000 cells were 
seeded and after various treatments, cells were harvested using trypsin, stained with 
0.4% trypan blue (Sigma T8154), and counted using a hemocytometer under phase 
contrast microscopy. For clonogenic studies, cells were plated in six well dishes at an 
appropriate density (specific cell numbers are mentioned in the figure legends). After 2 
weeks, the cells were washed with PBS, fixed with 100% methanol, air-dried and 
stained with 0.1% crystal violet (Sigma C3886). Cells in groups of 50 or more were 
counted as colonies and data were normalized relative to untreated controls.  Data is 
represented as number of colonies counted.  
 
2.4 FACS Analysis for Annexin V and Propidium Iodide positive cells to assess 
apoptosis. 
For FACS analysis, 20,000 cells were seeded and after different treatments, cells were 
collected and labeled fluorescently for detection of apoptotic and nectrotic cells. This 
assay works on the following principle: In early apoptosis, phosphophatidyl serine 
molecules are expressed on the outside of the cell membrane. Annexin V, which is 
fluorescently labeled with a molecule such as FITC, has great affinity for these 
phosphophatidyl serines and binds to them. This way cells in early apoptosis give out 
Annexin V signal. When cells are in late apoptotic stage, their membrane starts to break 
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apart and PI, which is an intercalating agent and binds to nucleic acids (RNA and DNA), 
is able to enter the cells and now cells stain positive for both annexin V and PI. However 
when cells become necrotic, the cell membrane completely disintegrates and all the 
cellular components (including phosphatidyl serines) get degraded. Cells, when necrotic 
stain positive only for PI.  
For sample preparation, cells were scraped off from the plate and washed twice with 
cold PBS. After the washes, they were re-suspended in 500 µl of 1x Binding Buffer 
(FITC AnnexinV apoptosis detection kit, BD Biosciences, San Jose, CA) with 5 µl of 
Annexin V-FITC, and 10 µl of propidium iodide (50 µg/ml). Samples were gently mixed 
and incubated at room temperature in the dark for 15 min. The percentage of cells with 
increased annexin/PI staining was assessed by flow cytometry and analyzed by BD 
FACSCanto II using FACSDiva software. A minimum of 10,000 cells within the gated 
region were analyzed. Staurosporine was used as positive control for this study. It is 
able to induce apoptosis by activating Caspase-3. 
 
2.5 Detection and quantification of senescent cells.   
The method described by Dimri et al. 1995, was used for detection of β-galactosidase 
positive cells. 20,000 cells were seeded and after treatment, cells were washed with 
PBS and fixed with 2 % formaldehyde/ 0.2% glutaraldehyde/PBS for 10-12 minutes. 
Cells were again washed with PBS and stained with 5-bromo-4-chloro-3-inolyl-β-D-
galactosidasec(X-Gal) in dimethylformamide (20 mg/ml), 40 mM citric acid/sodium 
phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 
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mM NaCl, and 2 mM MgCl2 and incubated at 37°C overnight. After incubation, the cells 
were washed twice with PBS and visualized using an Olympus inverted microscope.  All 
images were taken at the same magnification. Since senescent positive cells have high 
levels of β-galactosidase enzyme due to increased lysosomal mass, they break down X-
gal to form an insoluble blue color compound. The amount of this blue color compound 
is an indicator of the extent of senescence.  
For quantification of the senescence levels using FACS, 20,000 cells/well were seeded, 
treated as above and analyzed using a fluorescent β-galactosidase activity marker, 
C12FDG (Life technologies, D2893). The protocol was adapted from Debacq-Chainiaux 
et al. 2009. C12FDG  substrate is impermeable and non-fluorescent initially but once it 
gets hydrolyzed by β-galactosidase enzyme, it gets trapped and gives out a green 
fluorescence which can be quantified using flow cytometry.  
 
2.6 Detection and quantification of acidic vesicles with Acridine Orange staining.  
Cells were plated (20,000/well) in six well culture dishes, stained with acridine orange 
(Sigma 10mg/ml) at a final dilution of 1:10,000 in respective culture media and allowed 
to incubate at 37°C for 10 min. After one wash with PBS, cells were imaged under an 
inverted fluorescence microscope (Olympus, Tokyo, Japan). All images were taken at 
the same magnification. Acridine orange is a lysotropic dye, which is a hydrophobic 
green colored molecule at neutral pH but when pH becomes acidic, it gets protonated 
and gets entrapped in the acidic vesicle and emits bright orange/red signal.  
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For quantification of autophagic vesicles (AVOs), 20,000 cells were seeded and after 
different treatments, cells were trypsinized, harvested and washed with PBS. Pellets 
were re-suspended in 500μl PBS, stained with a 1:10,000 dilution of acridine orange for 
10 min and analyzed by BD FACSCanto II using BD FACSDiva software at the Virginia 
Commonwealth University Flow Cytometry Core Facility. A minimum of 10,000 cells 
within the gated region was analyzed.  
 
2.7 GFP-LC3 redistribution. 
GFP-LC3 plasmid was obtained from Addgene (22405). Retroviruses were produced in 
HEK 293TN cells transfected using Lipofectamine (Invitrogen, Carlsbad, CA). Viruses 
shed into the media were then used to infect H460 and A549 cells. Puromycin (1µg/ml) 
was used as the selection marker to enrich the infected cells. For sample preparation, 
cells were treated as described above, fixed with 3% paraformaldehyde, and visualized 
using a Leica Confocal laser-scanning microscope. Cells were counterstained with 
DAPI to stain and visualize the nucleus. GFP-LC3 is visualized either as a diffused 
cytoplasmic pool or as puncta structures that primarily represent autophagosomes.  
 
2.8 Western blotting. 
After the indicated treatments, cells were scraped from the culture dishes, collected and 
lysed using M-PER mammalian protein extraction reagent (Thermo Scientific, Waltham, 
MA) containing protease and phosphatase inhibitors. Protein concentrations were 
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determined by the Bradford assay (Bio-Rad Laboratories, Hercules, CA). Total protein 
was then diluted in SDS sample buffer and dry boiled for 10 min. Protein samples were 
subjected to SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene 
difluoride membrane, and blocked in 5% milk/1x PBS/ 0.1% Tween for 1 hour. Primary 
antibodies used at a 1:1000 dilution with overnight incubation were VDR (Sana Cruz 
Biotechnology), p62 (Santa Cruz Biotechnology, Santa Cruz, CA), LC3II (Cell signaling 
Technology), ATG5 (Cell Signaling Technology, Danvers, MA), BECN1 (Cell Signaling 
Technology), p53 (BD pharmingen),  phospho-AMPK (Cell signaling Technology), total-
AMPK (Cell signaling Technology), phospho-acetyl ACC (Cell signaling Technology), β-
actin (Santa Cruz Biotechnology). The membrane was then incubated with secondary 
antibody of either horseradish peroxidase-conjugated goat anti-rabbit IgG antibody 
(1:10,000; Sigma) or goat anti-mouse (1:10,000; Sigma) for 1 hour, followed by 
extensive washing with tween-PBS. Blots were developed using Pierce enhanced 
chemiluminescence reagents and Bio-Max film (Thermo Scientific).  
 
2.9 Assessment of kinase phosphorylation and γ-H2AX formation. 
20,000 cells/well were seeded and after different treatments, cells were washed twice 
with PBS, fixed with 4% paraformaldehyde for 10 min, permeabilized with 100% cold 
methanol for 30 min and incubated with blocking buffer (4% BSA in PBS) for 10 min. 
Cells were incubated with a 1:50 dilution of primary antibody for 1 hour, washed with 
PBS and incubated with a fluorochrome- conjugated secondary antibody (1:100 dilution) 
for 30 min in the dark. After the second incubation, cells were washed with blocking 
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buffer and re-suspended in 400 µl PBS. Cells were analyzed using FACS with a 
minimum of 10,000 cells for each sample (Gagou EM et al. 2010). Primary antibodies 
used were p-AMPK α1/α2 Thr172 (Cell Signaling), p-ULK-1 Ser317 (Cell signaling), and 
anti-γ-H2AX Ser139 (EMD Millipore, Billericia, MA).  
2.10 Statistical Analysis. 
Statistical differences were determined by StatView statistical software (SAS Institute, 
Cary, NC). The data were expressed as means ± SE (as standard error of the mean). 
Comparisons were made using one-way analysis of variance (ANOVA) followed by 
Bonferroni post hoc test, and p values ≤ 0.05 were taken as statistically significant.  
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Chapter 3 
 
Sensitization to Radiation by vitamin D.  
3.1 Influence of 1,25-D3 and the vitamin D analogue EB1089 on sensitivity to 
radiation in non-small cell lung cancer cells 
As indicated in the Introduction 1,25-D3 and EB 1089 can influence cell function only 
after they bind to vitamin D receptor (VDR). Therefore, we first employed western 
blotting to assess VDR levels in a spectrum of non-small cell lung cancer cell lines, 
specifically H460, A549, H1299, H838, H358, and H2030 cells. As shown in figure 3.1, 
VDR was found to be expressed at high levels in A549, H358, H460 cell lines and in 
moderate amounts in H1299 and H520 cells while VDR expression was not expressed 
in the H838 and H2030 cell lines.    
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In order to determine a suitable dose of radiation to be used for these studies, we 
performed clonogenic survival studies where cells were plated at a relatively low density 
(mentioned in the figure legends) and were treated with different doses of radiation 
ranging from 2Gy to 10Gy. Results were analyzed two weeks after the treatment. As 
shown in figure 3.2, radiation treatment inhibited colony forming ability of the cells at all 
doses used.  
We decided to employ 6Gy (60% inhibition of growth) in our subsequent studies in order 
to be able to study the sensitization/growth inhibitory effects of radiation and radiation + 
1,25-D3/EB1089 without killing the cells. As Vitamin D and its analogues have been 
shown to have anti proliferative effects in MCF7 breast tumor cells when used at 500 
nM concentrations  (Colston KW, et al. 1992), we performed clonogenic survival studies 
and cell viability studies using different concentrations of EB1089 and 1,25-D3 in order 
to assess their effects on lung tumor cell growth.  Modest growth inhibitory effects of 
vitamin D alone at 100nM had previously been shown in our laboratory in studies with 
MCF7 and ZR75 breast tumor cells (Demasters GA, et al. 2006; Wilson EN, et al. 
2011).  Clonogenic survival studies were carried out over a span of 2 weeks after 
EB1089/1,25-D3 treatment  for 24 hours. In both p53 wild-type cell lines, H460 and 
A549, EB1089 and 1,25-D3 had minimal growth suppressive/inhibitory effects as shown 
in figure 3.3. For cell viability studies, which were performed by trypan blue exclusion, 
vitamin D treatment was for 24 hours and cell viability was determined on days 1, 3, 5, 
and 7. Similar to the clonogenic survival studies, 1,25-D3 and EB1089 had minimal 
inhibitory effects on the growth of the two cell lines as shown in figure 3.4. The lack of 
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effect of these agents alone establishes that the sensitization effects observed are not 
simply the consequence of additive anti-proliferative or cytotoxic interactions.  
Further, in order to establish a concentration of vitamin D that could be used in radiation 
sensitization studies, clonogenic survival and cell viability studies were performed using 
different doses of EB 1089 ranging from 5 nM to 200 nM, in combination with a single 
dose of 6Gy radiation. Based on studies shown in Figure 3.5, which indicate that doses 
above 100nM become toxic, we established that a concentration of 100 nM would be 
used in combination with 6Gy for our studies. This is an identical concentration to that 
previously reported to sensitize breast tumor cells to radiation (Milczarek M et al. 2013; 
Demasters GA,et al. 2006; Sundaram S, et al. 2003). 
Treatment with 1,25-D3 and EB 1089 had an essentially identical impact in terms of 
tumor cell sensitization. Again, this is similar to our previous findings in studies with 
breast tumor cells. Consequently, while the bulk of studies in A549 cells were performed 
using 1,25-D3, studies in H460 cells were performed using  EB 1089, which tends to be 
more stable for prolonged periods in solution. Additionally, in terms of potential clinical 
utility, EB1089 has reduced calcemic effects (Prudencio J, et al. 2001).  
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Figure 3.1. Vitamin D receptor Status in NSCLC cell lines. VDR status in selected non-small 
cell lung cancer cell lines by Western blotting. Top band represents VDR.  
Figure 3.2. Radiation dose selection. Clonogenic survival studies were conducted with different 
doses of radiation in A549 and H460 cells to determine an appropriate dose to use for the 
studies. 200 cells/well were seeded for both A549 an dH460 cell lines and studies were carried 
out for a span of  two weeks (n=3, mean ± SE, *p<0.05 compared to control (0Gy)). 
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* * * 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Modest effects of 1,25-D3 or EB 1089 on cell survival. Clonogenic survival studies 
were conducted with different doses of 1,25-D3 and EB 1089 in A549 and H460 cells. These 
studies  indicate minimal inhibitory effects of 1,25-D3 and EB 1089 by themselves on survival. 
For A549 cell line 150 cells/well were seeded and for H460 cell line 200 cells were seeded. 
Studies were carried out for two weeks (n=3, mean ± SE; *p<0.05 compared to control) 
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Figure 3.4. Modest effects of 1,25-D3 or EB 1089 on cell viability. Cell viability studies were 
conducted with different doses of 1,25-D3 and EB1089 in A549 and H460 cells indicates 
minimal inhibitory effects on survival. Trypan blue exclusion assay was employed and studies 
were carried out for 7 days (n=3, mean ± SE).  
H460 
 
 
62 
* * 
* 
* * * 
* * * 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Dose response curve for the combination treatment of IR and EB 1089. 
Clonogenic survival  (upper panel) and cell viability studies (lower panel) were conducted with 
different doses of EB 1089 in combination with IR (6Gy) in H460 cells. Combination of 100 nM  
and 200 nM EB 1089 with 6Gy radiation dose sensitized the cells significantly (n=3, mean ± SE, 
*p<0.05; compared to IR alone).  
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3.2 Vitamin D sensitizes lung tumor cells to radiation:  
Clonogenic survival studies were performed with a single dose of radiation (6Gy) with a 
pretreatment of 24hrs with 100 nM of 1,25-D3/EB 1089. Figure 3.6 indicates that in both 
cell lines, H460 and A549, the combination of IR and EB1089/1,25-D3 produced a 
significant reduction in survival/reproductive capability of cells compared to radiation 
treatment alone.  
To assess the effects of the combination treatment of radiation + 1,25-D3/EB 1089 on 
cell viability, studies were performed using trypan blue exclusion in the A549 and H460 
NSCLC cell lines. 1,25-D3 and EB 1089 alone did not have any growth inhibitory effects 
on the cells as shown previously in Figure 3.4 upper and lower panels. Figure 3.7 
indicates that radiation (IR) alone produced significant inhibition of cell growth;  
however, after the initial growth arrest between days 3 to 6, cells started to show 
recovery at later time points starting at day 7 and going up to day 9 in both A549 and 
H460 cells. The combination treatment of IR and 1,25-D3/EB 1089 produced a more 
pronounced inhibition of  cell growth  and perhaps more importantly,  dampened the 
proliferative recovery at later time points in both A549 and H460 cell lines as shown in 
lower panels of figure 3.7.   
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Figure 3.6. Radiosensitization of NSCLC cells by 1,25-D3/EB 1089. Clonogenic survival 
studies were conducted with a single dose of 6Gy radiation (IR) alone or in combination with 
100 nM 1,25-D3 or 100 nM EB 1089 in A549 and H460 cells (n=3, mean ± SE, *p<0.05, values 
are compared to IR treatment; **p<0,05, values compared to control). These studies were 
carried out for a time period of 2 weeks.  
 
** 
** 
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* * * * * * * 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. 1,25-D3/EB 1089 increases radiosensitivity and inhibits proliferative 
recovery of NSCLC Cells. Cell viability studies were conducted with a single dose of 6Gy 
radiation (IR) alone and in combination with 100 nM 1,25-D3 or 100 nM EB 1089 in A549 and 
H460 cells (n=3, mean ± SE, *p<0.05 compared to IR). Lower panel are expanded versions 
of the figures shown in the upper panel. Cells were radio-sensitized and significant amounts 
of growth inhibition was observed with the combination treatment day 3 onwards.  
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3.3 Sensitization limited to cells with wt/functional p53 and VDR.  
Vitamin D sensitization studies were extended to other non-small cell lung cancer cell 
lines , specifically H358 cells , which have mutant p53 and H838 cells that are wild type 
in p53 but, which do not express vitamin D receptor. Unlike the outcome of studies  in 
H460 and A549 cells, which have wild type/functional p53, 1,25-D3 failed to sensitized 
H358 (mutant p53) cells to radiation as shown in figure 3.8 (upper panel). IR treatment 
alone inhibited growth of both cell lines, as would be expected. However, the 
combination treatment of IR and 1,25-D3 did not produce a growth inhibitory  effect  
greater than that produced by IR alone.  
Similar studies were also conducted in the H838 non-small cell lung cancer cell line, 
which lacks a functional vitamin D receptor. Since vitamin D requires VDR to be able to  
influence cell function we expected  that 1,25-D3 would fail to sensitize the H838 cells. 
Figure 3.8 (lower panel) indicates that  the combination treatment of IR+1,25-D3 was no 
more effective than  IR treatment alone. 
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* * 
* 
* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Lack of sensitization in p53 mutant and VDR lacking NSCLC cells. Cell 
viability studies conducted in H358 (upper panel) cells that express the VDR but are mutant in 
p53. Cell viability studies conducted in H838 cells (lower panel), which lack the VDR but are 
wild-type in p53. (n=3, mean ± SE; *p<0.05 compared to control). The combination treatment 
did not sensitize the cells to radiation indicating the requirement of both wt p53 and VDR in 
order to attain radio-sensitization.  
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3.4 Summary.  
1,25-D3 or EB 1089 alone  did not have any inhibitory effects on the growth (or survival) 
of the non-small cell lung tumor cells, A549 and H460. However, 1,25-D3 and EB 1089  
enhanced the sensitivity of these cells to radiation when used prior to radiation 
treatment. We have previously observed similar effects with vitamin D in breast tumor 
cell lines, MCF7 and ZR75 (Bristol ML, et al. 2012; Wilson EN, et al. 2011).  However, 
cells that are mutant in p53 were not sensitized by the combination treatment. These 
findings are consistent with previous studies where MDA-MB-231 breast tumor cells, 
which lack functional p53, were  not sensitized to radiation by 1,25-D3 or the vitamin D 
analogue EB 1089 (DeMasters GA, et al. 2006; Bristol ML, et al. 2012). Furthermore, 
we confirmed the requirement for the VDR in order for sensitization to occur. Taken 
together, these studies indicate a requirement for both wtp53 and the vitamin D receptor 
for sensitization to radiation by 1,25-D3/EB 1089.  
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Chapter 4 
 
Identifying the basis of radio-sensitization. 
 
4.1 1,25-D3 and the vitamin D analogue EB1089 fail to increase the extent of DNA 
damage or interfere with DNA repair in non-small cell lung cancer cells: 
In our previous studies with breast tumor cells, we failed to find evidence for increased 
DNA damage or decreased DNA repair associated with sensitization to radiation by 
1,25 D3/EB 1089 (Sundaram S, et al. 1999; Gewirtz DA, et al. 2002; Demasters GA, et 
al. 2006). It is quite common for cells to undergo DNA damage upon irradiation.  We 
assessed DNA damage in H460 cells by performing flow cytometry to measure levels of 
the phosphorylated DNA repair marker γH2AX in response to radiation and radiation + 
EB 1089. γH2AX is a sensitive marker to measure double strand DNA breaks and 
phosphorylation (at ser139) by upstream  sensors, specifically  ATM for ionizing 
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radiation and ATR for UV radiation. Breaks were monitored at 1 hour, when DNA 
damage is expected to be maximal and at 48 hours, when repair is likely to be 
complete. As shown in Figure 4.1, high levels of damage were observed at the earlier 
time points, but declined by the 8 hour time point in both A549 and H460 cells. 
Furthermore, neither the initial extent of damage nor the rate of decline (i.e. repair) was 
affected by the presence of 1,25-D3 or EB 1089. 
4.2 Minimal induction of apoptosis or necrosis by radiation and radiation + 1,25 
D3 /EB 1089 in NSCLC cells.  
To further obtain insight into how the sensitization might be occurring, studies were 
conducted to assess apoptosis  and necrosis in response to  treatment with IR alone 
and IR + EB 1089 by flow cytometry using  Annexin V/PI  staining in H460 and A549 
cells starting from Day 1 up to Day 7. Staurosporine, a protein kinase inhibitor, which is 
known to induce apoptosis, was used as a positive control (Bertrand R, et al. 1994; 
Watson SP, et al. 1988). AnnexinV/PI staining can distinguish cells undergoing early 
apoptosis, late apoptosis and necrosis. Phosphatidyl serine  is found on outer 
membrane of the cells when they are undergoing early apoptosis. Annexin V molecules, 
which are bound to a fluorescent FITC, have affinity for phosphatidyl serine, and bind to 
these molecules and then fluoresce. Early apoptotic cells stain positive only for annexin 
V. However, when cells are in their late apoptotic state,  the cell membrane begins to 
break open, which causes PI (an intercalating agent) to enter the cell. Late apoptotic 
cells stain positive for both annexin V and PI. In addition, cells that become necrotic 
stain positive only for PI since annexin V along with other cellular components is 
degraded during necrosis. As shown in Figures 4.2 and  4.4,  there was minimal 
 
 
71 
induction of apoptosis or necrosis by radiation alone and this was not increased to any 
significant extent by the combination treatment of radiation and 1,25-D3/EB 1089 in 
A549 and H460 cells. Quantification of results is represented in upper panels of figures 
4.3 and 4.5. 
Although annexinV/PI staining is an accurate and relatively specific assay for apoptosis, 
we sought to confirm (the relative absence of) apoptosis by assessing poly (ADP-
ribose) polymerase (PARP) cleavage using western blotting.  PARP is activated during 
DNA damage and is cleaved by active caspases. Again, Staurosporine was used as a 
positive control. As indicated in the lower panels of figures 4.3 and 4.5, the lack of 
PARP cleavage for both radiation and the combination treatment of IR and EB 1089 
confirmed our previous finding in both A549 and H460 cells.  
.  
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Figure 4.1. Induction and repair of DNA damage by IR and 1,25-D3/EB 1089 + IR. Induction 
and decline of DNA damage in A549 (upper panel) and H460 (lower panel) cells by FACS 
analysis of γH2AX levels after treatment with 100 nM 1,25-D3 and EB 1089 and 6Gy radiation 
alone and in combination (n=3 mean ± SE; *p<0.05, values are compared to control). 
Phosphorylation of γH2AX was observed to be induced as early as 1 hour and went down soon 
after by 8 hours.  
A549 
H460 
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Figure 4.2. Assessment  of apoptosis (and necrosis) induction in A549 cells by flow 
cytometry. Quantification of apoptosis in A549 cells by flow cytometry using annexinV/PI 
staining. Quadrants indicating both early and late apoptosis were taken into account. 
Staurosporine, which induces apoptosis by activating caspase3, was used as a positive control. 
These histograms show day 3 of a representative experiment. 
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Figure 4.3. Minimal increase in apoptosis in response to radiation sensitization in 
A549 cells. Representation of apoptosis quantification in A549 cells( n=3, mean ± SE). No 
significant increase in apoptosis was observed with any of the treatments (upper panel). 
PARP cleavage assessed by Western blotting on Days 3 and 5 (lower panel). Staurosporine 
was used as a positive control. Except for a slight band for IR Day3, no PARP cleavage was 
observed at other time points with different conditions.  
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Figure 4.4. Assessment  of apoptosis (and necrosis) induction in H460 cells by flow 
cytometry. Quantification of apoptosis in H460 cells by flow cytometry using annexin V/PI 
staining. Quadrants indicating both early and late apoptosis were taken into account. 
Staurosporine, which induces apoptosis by activating caspase3, was used as a positive control. 
These histograms show day 3 of a representative experiment. 
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Figure 4.5. Minimal increase in apoptosis in response to radiation sensitization in H460 
cells. Representation of apoptosis quantification in H460 cells( n=3, mean ± SE). No 
significant increase in apoptosis levels was observed for various treatment conditions (upper 
panel). PARP cleavage assessed by Western blotting  (lower panel) on Days 3 and 5. 
Staurosporine was used as a positive control. No significant PARP cleavage was observed for 
any of the treatment conditions.  
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4.3 1,25-D3 /EB 1089 fail to increase the extent of senescence induction by 
radiation in NSCLC cells.  
Since the primary response observed either with radiation alone or radiation + 1,25 D3/ 
EB 1089 appeared to be growth arrest, and since we previously demonstrated that the 
primary response to radiation in p53 wild type cells is senescence (Jones KR, et al. 
2005; Gewirtz DA, et al. 2008) in the absence of significant apoptosis, we evaluated 
whether the extent of senescence might have been altered for the combination 
treatments.  
To assess levels of senescence in A549 and H460 cells, we employed β-galactosidase 
staining (Dimri GP, et al. 1995) and x-gal, a chromogenic substrate, which when 
cleaved by β-galactosidase leads to formation of an insoluble blue color compound. The 
extent of blue color positive cells indicates senescence.  The β-galactosidase staining 
images shown in figures 4.6 and 4.8 for A549 and H460 cells indicate that both radiation 
treatment alone and the combination of radiation with 1,25-D3 or EB 1089 lead to an 
increase in senescence levels compared to control and 1,25-D3/EB 1089 treated cells. 
Alterations in morphology are another indication of senescence. Cells undergoing 
senescence become enlarged and flattened and form neuron-like arm projections from 
cells as indicated by β-galactosidase staining images for both A549 and H460 cells. 
Flow cytometry was employed to quantitatively measure the extent of senescence in our 
cell models utilizing a fluorogenic substrate C12FDG to stain the senescent positive cells 
(Debacq-Chainiaux F, et al. 2009). C12FDG is a membrane impermeable non 
fluorescent molecule which becomes trapped and produces green fluorescence when 
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hydrolyzed by β-galactosidase.   Figures 4.7 and 4.9 respectively  provide quantification 
of the time dependent increase in senescence induced by radiation and the combination 
treatments in A549 (figure 4.7) and H460 (figure 4.9) cell lines. These studies indicate 
an increase in senescence levels but fail to demonstrate any significant differences 
between radiation treatment alone and the combination of radiation + 1,25 D3/ EB 1089 
in terms of the extent of senescence. 
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Figure 4.6. Assessment of senescence induction by radiation and radiation + 1,25D3 in 
A549 cells.. β-galactosidase staining indicative of senescence in A549 cells after 6Gy radiation 
alone and the combination of IR (6Gy) + 1,25-D3. All images were taken at the same 
magnification. Extensive induction of senescence is observed in response to IR and IR+1,25-D3 
treatments as indicated by an increase in insoluble blue color compound formed by cleavage of 
x-gal by β-galactosidase. Images shown are from a representative experiment.  
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Figure 4.7. No significant increase in senescence by IR+1,25-D3 compared to IR in A549 
cells. Quantification of senescence by flow cytometry using fluorogenic substrate C12FDG in 
A549 cells. (n=3, mean ± SE; *p<0.05 compared to control). Fluorescent intensity produced by 
hydrolysis of this substrate by β-galactosidase  enzyme was measured by flow cytometry. 
Adriamycin used as a positive control. Histograms in the upper panel show day 3 of a 
representative experiment. 
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Figure 4.8. Assessment of senescence induction by radiation and radiation + EB 1089 in 
H460 cells. β-galactosidase staining indicative of senescence in H460 cells after 6Gy radiation 
alone and the combination of IR (6Gy) + EB 1089. All images were taken at the same 
magnification. Extensive induction of senescence is observed in response to IR and IR+1,25-D3 
treatments as indicated by an increase in insoluble blue color compound formed by cleavage of 
x-gal by β-galactosidase. Images shown are from a representative experiment.  
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Figure 4.9. No significant increase in senescence by IR+EB 1089 compared to IR in H460 
cells. Quantification of senescence by flow cytometry using a fluorogenic substrate, C12FDG in 
H460 cells. (n=3, mean ± SE). Fluorescent intensity produced by hydrolysis of this substrate by β-
galactosidase  enzyme was measured by flow cytometry. Adriamycin used as a positive control. . 
Histograms in the upper panel show day 3 of a representative experiment. 
 
 
 
 
83 
4.4 Evidence that autophagy is the mode of radio-sensitization by 1,25-D3/EB 
1089.  
We have previously reported quite extensively on the capacity of 1,25 -D3 and vitamin D 
analogs to sensitize breast tumor cells to radiation (Sundaram S, et al. 1999; Gewirtz 
DA, et al. 2002; Sundaram S, et al. 2003; Bristol ML, et al. 2012; Wilson EN, et al. 2011; 
Demasters GA, et al. 2006). In recent work, we have confirmed that this sensitization, a 
decline in viable cell number, occurs through the promotion of autophagy based on 
reversal of sensitization through either pharmacological or genetic interference with 
autophagy (Bristol ML, et al. 2012; Wilson EN, et al. 2011).  
In the current studies to investigate whether autophagy is the mode of sensitization in 
A549 and H460 cells, the cells were stained with acridine orange and acidic vesicle 
formation was assessed visually using fluorescence microscopy as well as 
quantitatively using flow cytometry. Acrdine orange is lysotropic dye, which accumulates 
in acidic vesicles in a pH dependent manner. It gives out green fluorescence at neutral 
pH but becomes protonated and trapped in acidic vesicles and gives out bright orange 
fluorescence. Figures 4.10 show acridine orange images captured for A549 and H460 
at day 3. Increased acidic vesicle formation is observed with the combination treatment 
of IR and 1,25-D3 in A549 cells. To quantify the amount of autophagy in the system, 
flow cytometry was used to measure the fluorescent intensity of acridine orange. 
Figures 4.11 show time dependent increase in acidic vesicle formation for radiation 
treatment alone and the combination of radiation and 1,25-D3 in A549 cell line. We 
observed significant differences between IR and IR+1,25-D3 induced autophagy in 
A549 cells. Serum starvation was used as a positive control. Cells were starved for 4 
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hours before they were analyzed. Both imaging and flow cytometry data confirmed that 
there is a significant increase in autophagy levels for IR treatment and combination 
treatment of IR and 1,25-D3 in A549 cells. However, as shown in Figure 4.12 and 4.13, 
the extent of autophagy was not significantly different for radiation alone and EB 1089 + 
radiation in the H460 cells.  
To confirm autophagy induction, we used confocal microscopy to assess LC3 puncta 
staining in the cytoplasm (Kirisako T, et al. 2000). A549 and H460 cells were stably 
transfected with a plasmid containing LC3 labeled with green fluorescent protein (GFP). 
Microtubule associated protein light chain 3 (LC3) is a mammalian homolog of yeast 
Atg8 found in the cytoplasm in LC3I form. Upon autophagy induction, LC3 conjugates 
with phosphatidylethanolamine (Atg8-PE) to form LC3II, which is then targeted to 
autophagosome membranes (Kuma A, et al. 2007; Klionsky DJ, et al. 2012). Therefore, 
GFP-LC3 is observed by  fluorescence microscopy either as a diffuse cytoplasmic pool 
in cells not undergoing autophagy or as puncta structures which essentially indicate 
autophagosome formation when autophagy is induced (Mizushima N, et al. 2010- 
methods in mammalian autophagy research).  The upper panels of figures 4.12 and 
4.15 show an increase in puncta formation for both radiation and the combination 
treatment of radiation and 1,25-D3/EB 1089 in A549 and H460 cells.  As with the 
acridine orange staining, we did not detect any major differences between the puncta 
induced by radiation alone and with the combination of radiation and EB 1089 in H460 
cells. 
Once it was determined that autophagy was being initiated, it was necessary to  assess 
autophagic flux to establish if autophagy was going to completion since formation of 
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autophagic vesicle does not necessarily mean that autophagosomes are fusing with 
lysosomes and that the cellular components are being degraded. We employed western 
blotting to assess degradation of the established autophagic marker p62 (Klionsky DJ, 
et al. 2012; Johansen T, et al. 2009). The p62 protein serves as a link between light 
chain 3 (LC3) protein and ubiquitinated substrates. p62 and p62 bound ubiquitinated 
proteins are incorporated into autophagosomes and are degraded when 
autophagosomes fuse with lysosomes. Autophagic flux correlates with decreased p62 
levels (Klionsky DJ, et al. 2012). Another protein marker for autophagic flux that was 
assessed by Western blotting is microtubule associated light chain II, which is recruited 
to the autophagosomal membrane during formation of the autophagosome. LC3II is 
also  degraded by lysosomal enzymes when autophagosomes fuses with  lysosomes.  
Both p62 and LC3II appear to be degraded over time for both radiation treatment and 
the combination treatment of radiation and 1,25-D3/EB 1089 compared to no treatment 
and EB1089 treatment alone as shown in figures 4.12 and 4.15 (lower panels). These 
data further indicate that there was no apparent  difference in the extent of autophagic 
flux between radiation alone and the combination of radiation and 1,25-D3/EB 1089, 
indicating that autophagic flux is unlikely to be a distinguishing characteristic. LC3II 
bands appear to degrade slower than p62 because LC3II is present both outside and 
inside the autophagosomes due to which even when LC3II inside the autophagosome 
starts to degrade, there is some present on the outside of the membrane which 
degrades later in the end.  
These studies suggest that although we see a significant increase in autophagy levels 
with the combination treatment of radiation and 1,25-D3 as compared to IR alone in 
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A549 cells, there is only a modest difference in autophagy levels for radiation alone and 
the combination of IR and EB1089 in H460 cells arguing against  the simple explanation 
that sensitization might be caused solely by an increase in the extent of autophagy.  
There is evidence in literature indicating that autophagy can play more than one 
functional role in response to different treatment conditions (Dutta D, et al. 2013; Zhang 
TZ, 2014; Gewirtz DA, et al. 2014) Studies show that it can either be cytoprotective or 
cytotoxic in nature. This prompted us to determine what functions was autophagy 
playing in response to IR and IR+EB 1089 in the NSCLC cell model. 
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Figure 4.10. Analysis of autophagy induction by acridine orange staining in A549 
NSCLC Cells. Acridine orange staining indicate induction of autophagy in A549 cells by 
radiation (IR, 6 Gy) alone or radiation+1,25-D3. All images were taken at the same 
magnification. Extensive amounts of Autophagy induction is observed for both IR and the 
combination treatment of IR+1,25-D3 as indicated by high amounts of orange/red colored 
autophagic vesicles.  
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Figure 4.11. Assessment of autophagy by flow cytometry in A549 NSCLC Cells. Quantification 
of autophagy by Flow cytometry in A549 cells using acridine orange staining. (n=3, mean ± SE, 
*p<0.05). Serum starved cells (4 hours) were used as positive control. Time dependent increase in 
autophagic vacuolar organelle formation was observed in response to both treatments. However 
the increase in autophagy levels with the combination is significantly higher than IR treatment 
alone. . Histograms in the upper panel show day 3 of a representative experiment. 
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Figure 4.12. Assessment of autophagic flux in A549 NSCLC Cells. Assessment of GFP-LC3 
puncta by confocal microscopy in A549 cells on day 3 are shown in the upper panel (all images 
were taken at same magnification). Increase in LC3II puncta formation was observed for both IR 
and the combination of IR+1,25-D3 treatments. Assessment of autophagic flux markers, p62 and 
LC3II in response to different treatment conditions by Western blotting shown in the lower panel. 
Degradation of p62 indicate autophagic flux when cellular components in the autophagosome are 
broken down.  
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Figure 4.13. Analysis of autophagy induction by acridine orange staining in H460 NSCLC 
Cells. Acridine orange staining indicating induction of autophagy in H460 cells by radiation (IR, 6 
Gy) alone or radiation + EB 1089. All images are taken at the same magnification. Extensive 
amounts of Autophagy induction is observed for both IR and the combination treatment of IR+EB 
1089 as indicated by high amounts of orange/red colored autophagic vesicles.  
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Figure 4.14. Assessment of autophagy by flow cytometry in H460 NSCLC Cells. 
Quantification of autophagy by Flow cytometry in H460 cells. (n=3, mean ± SE; *p<0.05 
compared to control). Serum starved cells used as positive control. Serum starved cells (4 
hours) were used as positive control. Time dependent increase in autophagic vacuolar 
organelles formation was observed in response to both IR and IR+EB 1089. No significant 
differences between IR and IR+EB 1089 were observed. . Histograms in the upper panel 
show day 3 of a representative experiment. 
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Figure 4.15. Assessment of autophagic flux in H460 NSCLC Cells. Assessment of GFP-LC3 
puncta by confocal microscopy in H460 cells on day 3 are shown in the upper panel (all images 
were taken at same magnification). Increase in LC3II puncta formation was observed for both IR and 
the combination of IR+EB 1089 treatment. Assessment of autophagic flux markers, p62 and LC3II in 
response to different treatment conditions by Western blotting shown in the lower panel. 
Degradation of both p62 and LC3II indicate autophagic flux when cellular components in the 
autophagosome are broken down.  
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4.5 Autophagy induced by radiation treatment is cytoprotective in nature.  
It has been established by a number of laboratories, including our own, that radiation-
induced autophagy frequently has a cytoprotective function (Bristol ML, et al. 2012; 
Wilson EN, et al. 2011). Recent studies by Kroemer’s lab have shown this to be the 
case in the A549 and H460 cells by demonstrating that inhibition of radiation induced 
autophagy increases sensitivity to radiation (Ko A, et al. 2014) and this has been 
confirmed in our current work. We performed cell viability studies using trypan blue after 
inhibiting radiation-induced autophagy using both pharmacological and genetic 
approaches.  The pharmacological inhibitors used for this study were chloroquine and 
bafilomycin. Chloroquine is an anti-malarial drug which enters the acidic vacuoles by 
diffusion and alters the pH, which interferes with the fusion between lysosomes and 
autophagosomes (Klionsky DJ, et al. 2012). Bafilomycin, which is a H+ATPase enzyme 
inhibitor, works on a similar principle in that it alters the pH of the vacuoles and 
interferes with the activation of lysosomal enzymes (Klionsky DJ, et al. 2012; Tapper H, 
et al. 1997). Both chloroquine and bafilomycin are late stage autophagy inhibitors. We 
first performed an MTT assay using different doses of these inhibitors to determine 
suitable concentrations to be used for our studies, which would have minimal or 
(preferably) no toxic effects. Based on the results as shown in figure 4.16 and the 
literature we decided to use concentrations of 10 μM for chloroquine and 100 nM for 
bafilomycin. 
Cell viability studies were also performed to determine growth inhibitory effects of the 
inhibitors over a longer period of time. Figure 4.17 shows that neither of the inhibitors   
altered cell viability compared to untreated control cells.  
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Acridine orange staining was employed to confirm that autophagy was blocked using 
these pharmacological inhibitors by visualizing the acridine orange stained vacuoles. 
Autophagy inhibition was confirmed in A549 cells (figure 4.18 upper panel) and H460 
(figure 4.20 upper panel) cells. Since both chloroquine and bafilomycin are late stage 
inhibitors of autophagy, they lead to an accumulation in acidic vesicle since they block 
lysosome form fusing to autophagosome by altering the pH of the acidic vesicles. 
Furthermore, since these inhibitors alter the pH of the vesicles, the change in color from 
orange to yellow provides an additional confirmation of autophagy inhibition. Finally, 
assessing levels of the p62 protein by Western blotting confirmed autophagy inhibition 
in A549 (figure 4.18, lower panel) and H460 (figure 4.20, lower panel) cells. 
Accumulation of p62 when chloroquine and bafilomycin were used indicated that the 
autophagic process was prevented from going into completion.  
Cell viability studies shown in Figures 4.19 and 4.21 demonstrate that a 
pharmacological blockade to autophagy resulted in an increase in sensitivity to radiation 
and a pronounced inhibition of cell growth as indicated by decrease in cell viability. 
Although figures 4.22, 4.23, 4.24 and 4.25 show that blocking autophagy using 
pharmacological inhibitors led to a significant increase in apoptosis when assessed by 
flow cytometry using annexinV/PI staining in A549 cells but did not do so in H460 cells. 
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Figure 4.17. Minimal effect of autophagic inhibitors on cell viability. Cell viability studies were 
performed in H460 cells to assess growth inhibitory effects of autophagy inhibitors, chloroquine 
and bafilomycin at 10 μm and 100 nM concentrations, respectively.  Both inhibitors showed 
minimal inhibitory effects on cell viability.  
 
 
Figure 4.16. Dose response with autophagy inhibitors Chloroquine and Bafilomycin A1. 
MTT assay to assess cell toxicity of autophagy inhibitors, chloroquine and bafilomycin in H460 
cells after 48 hours. Staurosporine (1μM) used as a positive control. Neither of the inhibitors were 
found to be toxic to cells (n=3, mean ± SE, *p<0.05, compared to control).  
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Figure 4.18. Inhibition of radiation induced autophagy in A549 cells. Acridine orange staining 
indicating autophagy inhibition by chloroquine (upper panel; all images taken at same 
magnification on day 3). Chloroquine interferes with the acidification step and turns orange color 
of vesicles to yellow. Western blotting indicating autophagy inhibition by accumulation of 
autophagic flux marker p62 in the presence of chloroquine on Day3 (lower panel). 
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Figure 4.19. Cytoprotective autophagy induced by radiation in A549 cells. Evidence that 
autophagy induced by radiation (IR, 6 Gy) alone is cytoprotective in A549 cells based on 
increase in radiation sensitivity when autophagy is blocked by chloroquine (n=3, mean ± SE, 
#p<0.001). These studies were carried out for a time period of 9 days.  
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Figure 4.20. Inhibition of radiation induced autophagy in H460 cells. Acridine orange staining 
(upper panel) indicate autophagy inhibition with use of chloroquine and bafilomycin A1. Again, 
both chloroquine and bafilomycin A1 interfere with the acidification step and further turn the 
orange color of the vesicles to yellow. (all images were taken at the same magnification on day 3).  
Western blotting (lower panel) indicating autophagy inhibition by accumulation of autophagic flux 
marker p62 in presence of chloroquine.and bafilomycin.  
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Figure 4.21. Cytoprotective autophagy induced by radiation in H460 cells. Evidence that 
autophagy induced by radiation (IR, 6 Gy) alone is cytoprotective in H460 cells based on 
increase in radiation sensitivity when autophagy is blocked by pharmacological inhibitors 
chloroquine (upper panel) and bafilomycin (lower panel) (n=3, mean ± SE,*p<0.05; #p<0.001). 
Studies were carried out for a time period of 5 and 7 days. 
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 Figure 4.22. Assessment of apoptosis upon inhibition of autophagy in A549 cells by flow 
cytometry. Quantification of apoptosis by flow cytometry using annexin V/PI staining on day 3. 
These studies indicate an increase in apoptosis upon inhibition of radiation induced autophagy in 
A549 cells. Staurosporine used as a positive control. 
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Figure 4.23. Induction of apoptosis upon inhibition of autophagy in A549 cells Measure 
of apoptosis when radiation induced autophagy is blocked using chloroquine in A549 cells 
(n=3, mean ± SE, *p<0.05). induction in apoptosis levels is observed on day 3 when 
autophagy is inhibited using chloroquine (10 μM).  
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Figure 4.24. Assessment of apoptosis upon inhibition of autophagy in H460 cells by flow 
cytometry. Quantification of apoptosis by flow cytometry using annexin V/PI staining on day 3. 
These studies indicate the increase in apoptosis upon inhibition of radiation induced autophagy 
is not statistically significant in H460 cells. Staurosporine used as a positive control. 
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Figure 4.25. Induction of apoptosis upon inhibition of autophagy in H460 cells. Measure 
of apoptosis when radiation induced autophagy is blocked using bafilomycin A1(10 μM)  and 
chloroquine (100 nM) in H460 cells on day 3 (n=3, mean ± SE). We did not observe a 
statistically significant increase in apoptosis upon autophagy inhibition with either of the 
inhibitors. 
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4.6. Increased sensitivity to  the combination treatment of IR + EB 1089  is 
associated with a novel form of autophagy 
To substantiate if autophagy is the mode of radiosensitization in response to the 
combination treatment of IR and EB 1089, we first determined whether interference with 
autophagy could reverse the impact of radiation + EB 1089. Again, we employed 
chloroquine and bafilomycin, both well-characterized pharmacological inhibitors of the 
late stages of autophagy (Klionsky DJ, et al. 2012). In addition, an shRNA strategy was 
used to knock down autophagy related genes such as ATG5 and BECN1. ATG5 is 
necessary for autophagy due to its involvement in autophagosome elongation 
(Mizushima N, et al. 2007). BECN1 is a mammalian ortholog of the yeast autophagy 
gene Atg6 that binds to class III phoshoinositide 3-kinase (PI3K) and is required for 
initiation of the formation of  the autophagosome  (Mizushima N, et al. 2007).  
Acridine orange images shown in figure 4.26 confirm that autophagy was blocked by 
using pharmacological inhibitors in combination with both IR and IR+EB 1089. As 
mentioned before, both being late stage inhibitors lead to an increase in accumulation of 
acidic vesicles. Furthermore, figure 4.20 (lower panel) shows Western blots indicating 
that both inhibitors CQ and bafilomycin  by themselves and in combination with radiation 
and EB1089, lead to an accumulation of p62, indicative of the inhibition of autophagic 
flux (Klionsky DJ, et al. 2012). 
 As shown in Figure 4.27, cell viability studies demonstrate that both chloroquine and 
bafilomycin, when used to block autophagy, reversed the radiosensitization effects of 
EB1089. This indicates that what we have termed a cytostatic form of autophagy (based 
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on the temporal response studies presented in Figure 3.7) is likely to be the mode of 
radiosensitization with the combination treatment. This conclusion is strongly supported 
by complementary genetic silencing studies, where the autophagy related genes 
BECN1 and ATG5 were knocked down utilizing shRNA as shown in the immunoblots in 
figure 4.28. Acridine orange images show a reduction in acidic vesicle formation 
confirming inhibition of autophagy as shown in figure 4.29. Cell viability studies shown in 
figure 4.30 after genetic silencing of BECN1 and ATG5 corroborate with the results of 
the pharmacological inhibition experiments. These studies further support our 
hypothesis that exposure of the NSCLC cells to 1,25 D3 or EB 1089 could be 
altering the function of the autophagy induced by radiation, converting the 
cytoprotective autophagy to what we have termed cytostatic autophagy as 
indicated in figure 4.31 and 4.32. 
We further performed annexin V/PI staining assay to assess apoptosis when autophagy 
was inhibited. As indicated in figure 4.33 blocking autophagy did not significantly alter 
the level of apoptosis in response to the combination treatment of IR and EB 1089. 
However we do see an increase in apoptosis levels when radiation induced autophagy 
is inhibited which is expected due to the known cytoprotective nature of autophagy.  
It is important to note that the sensitization to radiation that occurs when the 
cytoprotective autophagy induced by radiation is inhibited (Figure 4.12) is no longer 
evident in the cells exposed to EB 1089 + radiation; otherwise, it would be difficult to 
reverse the sensitization induced by EB 1089, a problem we encountered in our studies 
in breast tumor cells (Wilson EN, et al. 2011; Bristol ML, et al. 2012). Where, inhibiting 
autophagy induced by the combination treatment sensitized the cells since IR induced 
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autophagy was getting inhibited as well. This is the basis for our conclusion that the 
cytoprotective form of autophagy induced by radiation has been converted to a 
cytostatic form as shown in figures 4.29 and 4.30.  
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Figure 4.26. Evidence for inhibition of autophagy by chloroquine and bafilomycin A1 in 
H460 cells. Inhibition of autophagy indicated by increased acidic vesicle formation on use of 
late stage autophagy inhibitors, chloroquine (10 µM ) or bafilomycin (100 nM) in combination 
with IR and IR+ EB1089 in H460 cells on day 3 (all images were taken at the same 
magnification). Both inhibitors interfere with the acidification step in the autophagy process and 
further turns the orange color of the vesicles to yellow.  
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Figure 4.27. Evidence that radiosensitization by EB 1089 occurs through a cytostatic 
function of autophagy. Cell viability studies were conducted with autophagy inhibitors, 
chloroquine (CQ, 10 µM; upper panel) or bafilomycin A1 (baf, 100 nM; lower panel) for a period 
of 5 days in h460 cells. (#p<0.001; *p<0.05; n=3, mean ± SE). Reversal in sensitization is 
observed when autophagy is blocked using either chloroquine or bafilomycin.  
 
 
 
 
 
109 
 
 
 
 
 
 
 
 
 
 
Figure 4.28. Knockdown of autophagy related genes, ATG5 and BECN1, in H460 cells. 
Western blotting indicating knockdown of autophagy related genes, ATG5 and BECN1, in H460 
cells.  
 
 
 
 
 
Figure 4.29. Inhibition of autophagy by genetic silencing of ATG5 and BECN1 in H460 
cells. Decreased acidic vesicle formation when compared to control IR and IR+ EB 1089 
treated samples, indicate autophagy inhibition in H460 shBECN1 and shATG5 cells on day 3 
(lower panel) (all images were taken at the same magnification).  
 
 
 
 
 
 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30. Genetic knockdown of ATG5 and BECN1 reverses EB 1089 induced 
radiosensitization. Cell viability studies were conducted to assess the effects of ATG5 and 
BECN1 knockdown in H460 cells. Increase in cell count after genetic knockdown of ATG5 
and BECN1 indicates reversal in radiosensitization (n=3, mean ± SE, *p<0.05, #p<0.001).  
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Figure 4.31. EB 1089 causes a change in function of autophagy as indicated upon 
autophagy inhibition by knockdown of ATG5 gene.  Change from cytoprotective function 
(in response to radiation) to cytostatic function (in response to the combination of IR+EB 
1089) evident upon inhibition of autophagy by knocking down autophagy related gene ATG5. 
Cell viability studies were carried out for a time period of 7 days (n=3, mean ± SE, *p<0.05, 
#p<0.001). 
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Figure 4.32. EB 1089 causes a change in function of autophagy as indicated upon 
autophagy inhibition by knockdown of BECN1 gene.  Change from cytoprotective function 
(in response to radiation) to cytostatic function (in response to the combination of IR+EB 
1089) evident upon inhibition of autophagy by knocking down autophagy related gene 
BECN1. Cell viability studies were carried out for a time period of 7 days (n=3, mean ± SE, 
*p<0.05, #p<0.001). 
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Figure 4.33. Influence of genetic silencing of autophagy on apoptosis induction by IR 
and IR+EB 1089 in H460 cells. Apoptosis induction upon autophagy inhibition assessed by 
flow cytometry on day 3. Annexin V/ PI staining was done to assess both early and late 
apoptosis.  (n=3, mean ± SE; *p<0.05). Upon inhibition of autophagy by knockdown of ATG5 
and BECN1, there was an increase in  apoptosis in response to radiation and response to 
IR+EB 1089 remained unchanged. 
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4.7. Effects of radiation and EB 1089 + radiation are associated with cell cycle 
arrest 
As shown in the temporal response studies presented in Figure 3.7,  the primary effects 
of radiation as well as radiation in combination with either  1,25-D3 or EB 1089 were to 
arrest cell growth without evidence for cell killing in either condition. To confirm these 
observations, cell cycle analysis was performed in H460 cells exposed to radiation 
alone and EB 1089 + radiation with and without knock down of the autophagy genes 
ATG5 and BECN1.  As depicted in Figure 4.34, radiation alone as well as EB 1089 + 
radiation reduced the S phase population and increased the G2/M phase population. 
Effects of EB 1089 alone were not significant, again consistent with its lack of effect on 
cell growth. As would be expected, inhibition of autophagy by genetic silencing reversed 
the G2/M associated growth arrest.    
 
 
 
 
 
 
 
 
 
 
 
115 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.34. Cell Cycle analysis. Cell cycle analysis was performed in H460 (shcont, shATG5, 
and shBECN1) cells. Percentage of cells undergoing S-phase is shown in upper panel (n=2, 
mean ± SE, *p<0.05). Percentage of cells arresting in G2/M phase is shown in lower panel. (n=2, 
mean ± SE, *p<0.05). 
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4.8. Effects of 1,25-D3 and EB 1089 on radiation sensitivity in normal cells.  
Drug selectivity is a critical consideration in cancer related studies; treatments should 
ideally be highly targeted to minimize the damage to normal cells and tissue.  This is 
particularly true for the utilization of radiation in diseases such as non-small cell lung 
cancer. Consequently, studies were conducted to test for selectivity of the combination 
treatment of 1,25-D3 with radiation in normal human bronchial epithelial cells and 
cardiomyocytes in culture.  As with the experiments in H460 cells, the HBEC3-KT 
bronchial epithelial cells were pretreated with 100 nM EB 1089 24hours before 
irradiation with a single dose of 6Gy while the H9C2 cardiomyocytes were exposed to 
100nM 1,25-D3 for 24 hours followed by a single dose of radiation (5 Gy). Figures 4.34 
and 4.35 indicate that there were no significant differences between the impact of 
radiation alone and the combination of radiation + 1,25-D3 or radiation + EB 1089 
treatments in the epithelial cells or the cardiomyocytes. This suggests that if we can 
make radiation treatment focused and limit it to specific tumor site, we can use the 
combination treatment in clinics since vitamin D by itself does not have any toxic effects.   
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Figure 4.36. No difference in sensitization by IR compared to IR+1,25-D3 in human 
bronchial epithelial cells.  Cell viability studies were conducted in Human bronchial epithelial 
cells after exposure to 100nM 1,25D3, radiation (IR, 6Gy), or 100nM 1,25D3 prior to irradiation 
(6 Gy). 1,25-D3 by itself showed moderate inhibitory effects on the growth of cells. No 
significant differences between treatments of IR and the combination of IR+ 1,25-D3 were 
observed (n=3, mean ± SE, *p<0.05 compared to control). 
 
 
 
Figure 4.35. No difference in sensitization by IR compared to IR+1,25-D3 in 
cardiomyocytes. MTT assay conducted in H9C2 cardiomyocyes after exposure to 100nM 1,25-
D3 for 24 hours followed by radiation.  (5 Gy).  (n=3, mean ± SE). No significant differences 
between treatments of IR and the combination of IR+ 1,25-D3 were observed. 1,25-D3 by itself 
did not have any inhibitory effects on the growth of cells. 
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4.9. Summary. 
Initially, data pertaining to autophagy induction produced in A549 cells indicated that an 
increase in autophagy could be the mode of sensitization in response to the 
combination treatment in NSCLC. This conclusion was further supported by data 
demonstrating lack of other modes of sensitization such as DNA damage, apoptosis, 
and senescence. A number of studies used to assess autophagy indicated that there 
was a significant increase in autophagy levels in response to both IR and the 
combination treatment of IR + 1,25-D3/EB 1089. However, studies conducted in H460 
made a strong case that an increase in autophagy levels was not responsible for the 
sensitization but that there had been a switch in autophagic function.  
Pharmacological and genetic inhibition studies indicated that the functions of autophagy 
produced in response to radiation and IR + EB 1089 were different in nature. Inhibition 
of radiation induced autophagy led to an increase in sensitization, supporting the 
premise of cytoprotective autophagy being activated in response to radiation alone. This 
sensitization to radiation by autophagy inhibition appears to be a result, in part, from an 
increase in apoptosis. On the other hand inhibition of autophagy induced by the 
combination treatment led to a reversal in sensitization. These studies  support our 
hypothesis that exposure of the NSCLC cells to 1,25 D3 or EB 1089 could be 
altering the function of the autophagy induced by radiation, converting the 
cytoprotective autophagy to what we have termed cytostatic autophagy.   
Cell cycle studies performed with H460 cells showed growth arrest in response to both 
IR and the combination treatment of IR and EB 1089, which was reversed when 
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autophagy was inhibited by knockdown of autophagy related genes, ATG5 and BECN1. 
Studies conducted with normal human epithelial cells and cardiomyocytes indicate the 
possibility of the combination treatment being clinically relevant since the growth 
inhibition resulting from the combination treatment is no greater than that caused by 
radiation alone.  
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Chapter 5 
 
Exploring the signaling pathways involved 
in vitamin D mediated radio sensitization 
The studies described in this chapter were designed to establish and understand 
signaling pathways involved in vitamin D mediated radio-sensitization and furthermore 
to distinguish the signaling pathways that might be involved in altering the different 
functions of autophagy.  
5.1. p53’s involvement in radio-sensitization by vitamin D. 
In our previous work with breast tumor cells, we identified a fundamental requirement 
for functional p53 in radiosensitization by 1,25D3/EB 1089 (Sundaram S, et al. 1999; 
Bristol ML, et al. 2012; Wilson EN, et al. 2011). Both A549 and H460 cells are known to 
express wild type p53 (Cheng G, et al. 2013; Lorin S, et al. 2013). We showed earlier 
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that the combination treatment of radiation +EB 1089 failed to increase sensitivity to 
radiation in the H358 NSCLC cell line (Figure 3.8), which has mutant p53, despite the 
very high expression of the VDR (Figure 3.1). 
To confirm the requirement for functional p53 in radiosensitization, we employed H1299 
cells which are p53 null (Zhang F, et al. 2008). H1299 p53 null cells were  transfected in 
order to make them express p53 in the presence of doxycycline (1 μg/ml). The 
expression of p53 induced by doxycycline was confirmed by  Western blotting as shown 
in figure 5.1.  Further we demonstrate (Figure 5.2 A & B, where 5.2B is an expanded 
scale for IR and IR+EB 1089) that sensitization to radiation by EB 1089 fails to occur in 
the H1299 NSCLC cell line, which is p53 null, but expresses the VDR (Figure 3.1).  In 
dramatic contrast, figures 5.3 A & B (5.3B is an expanded scale for IR and IR + EB 
1089) indicate that H1299 cells could be radiosensitized by EB 1089 when p53 was 
expressed under the influence of doxycycline.  
We performed acridine orange staining to confirm that the induction of autophagy 
occurred in both cell lines in response to the different treatment conditions. Both H1299 
parental cells which are p53 null (-Dox) and H1299 cells with induced p53 (+Dox) 
showed a significant increase in acidic vesicle formation with both IR and the 
combination of IR+EB 1089 as shown in figures 5.4 and 5.5.  
To confirm and extend these observations in the H1299 cells, we investigated the 
effects of both pharmacological and genetic autophagy inhibition in both the p53 null 
and inducible cell lines. We performed acridine orange staining to ensure that 
autophagy was being inhibited using chloroquine in H1299 p53 null ( -Dox) and p53 
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induced (+Dox) cells. Figures 5.6 and 5.7 show an accumulation of acidic vesicles when 
chloroquine is used in combination with IR+EB 1089 in both H1299 (-Dox) and H1299 
(+Dox) cells since it is a late stage autophagy inhibitor. Further, figure 5.8 shows that 
chloroquine effectively promoted accumulation of LC3II, which is indicative of 
interference with the late stage of autophagy in both p53 null (-Dox) and p53 inducible 
(+Dox) H1299 cells. We performed cell viability studies to assess the effect of 
pharmacological inhibition of autophagy on cell growth. Figure 5.9 indicates that in 
H1299 cells with induced p53 (+Dox), sensitization of the combination treatment was 
reversed when autophagy was blocked using chloroquine.  In quite dramatic contrast,  
blocking autophagy in the p53 null H1299 parental cells (-Dox) had minimal effect  on 
tumor cell sensitivity to the combination treatment of EB1089  + radiation ( Figure 5.9). 
For genetic silencing studies, as shown in figure 5.10, both  Atg5 and Beclin-1 were 
successfully knocked down for p53 null (-Dox) and p53 inducible (+Dox) H1299 cells. 
Figures 5.11 and 5.12 show the reduction in autophagic vesicle formation when Atg5 
and Beclin-1 were knocked down in both p53 null (-Dox) and p53 inducible (+Dox) 
H1299 cells. Similar to the pharmacological inhibition studies, genetic inhibition of 
autophagy in the p53 induced cell line (+Dox) led to a reversal in sensitization compared 
to H1299 p53/null (-Dox), where no change with autophagy inhibition was observed as 
shown in figures 5.13 and 5.14. 
It should be noted that the low cell number for radiation alone in Figures 5.9B, 5.13B 
and 5.14B reflects sensitization to radiation through interference with the cytoprotective 
function of radiation-induced autophagy. Conversely, the high cell numbers for the EB 
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1089 + radiation combination reflects the fact that sensitization was eliminated through 
interference with cytostatic autophagy. 
5.2. The AMPK signaling pathway: 
AMPK, an energy sensor protein kinase, has been shown to be involved in regulating 
autophagy (Hardie DG, et al. 2012; Inoki K, et al. 2012). Studies were performed to 
investigate changes in AMPK levels by measuring its phosphorylation at Threonine 172 
site, in response to radiation alone (cytoprotective autophagy) and radiation + EB1089 
(putatively cytostatic autophagy).   
Western blotting was employed to assess the changes in phosphorylation levels of 
AMPK and flow cytometry was used to quantitate and measure the percentage of 
phosphorylated proteins. All of these studies were performed at early time points, 4 and 
12 hours. As indicated in the western blot shown in figure 5.15, we observed an 
increase in pAMPK levels as early as 4hrs in cells receiving the combination treatment 
of IR+EB1089 compared to cells receiving IR treatment alone. At both the 4 and 12 hour 
time points, AMPK activation by the combination treatment significantly exceeded that 
for radiation alone as indicated in figures 5.16.  
To potentially distinguish between the involvement of AMPK in autophagy signaling by 
radiation alone and radiation + EB1089, compound C, a pharmacological inhibitor of 
AMPK was used (Yang WL, et al. 2012). Western blotting was performed to 
demonstrate that compound C was able to inhibit radiation and radiation+EB1089 
induced AMPK phosphorylation as shown in figure 5.17. We also evaluated 
phosphorylation levels of Acetyl-CoA carboxylase (ACC), a downstream target of AMPK 
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(Vazquez-Martin A, et al. 2013). Inhibition of the phosphorylation of ACC further 
confirmed compound C’s effect. Figure 5.18 indicates that compound C by itself did not 
have any effect on the viability of cells. Autophagy was monitored by assessing GFP-
LC3 redistribution 12 hours post treatment by confocal microscopy as shown in figure 
5.19. Compound C treatment significantly diminished LC3 redistribution in IR and IR+EB 
1089 treated cells. Furthermore, figure 5.20 (lower panel) shows that inhibition of AMPK 
by compound C resulted in reversal of the radiosensitizing effects of EB 1089. In 
dramatic contrast, treatment with compound C enhanced the response to radiation 
alone as shown in figure 5.20 (upper panel). Consequently, these findings closely 
parallel the outcome of the experiments presented earlier, where autophagy inhibition 
enhanced sensitivity to radiation but reversed the enhancement of radiation sensitivity 
by EB 1089. These studies support the premise that autophagy has diametrically 
opposite functions in the case of radiation alone (cytoprotective) and radiation + EB 
1089 (cytostatic/radiosensitizing).   
 
 
 
 
 
 
 
Figure 5.1. Induction of p53 in H1299 cells indicated by western blotting. Western blotting 
indicating expression of p53 in the presence doxycycline (1ug/ml)  of in H1299 cells, which are 
otherwise p53 null. 
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 Figure 5.2. Lack of radiosensitization by EB 1089 in p53 null (-Dox) H1299 cells. Cell 
viability studies indicating lack of sensitization to IR+EB 1089 treatment in p53 null H1299 (-
Dox) (n=3, mean ± SE; *p<0.05 compared to control). No radio-sensitization was observed with 
the combination treatment of IR + EB 1089.  
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Figure 5.3. Radiosensitization by EB 1089 in p53 induced (+Dox) H1299 cells. Cell 
viability studies indicating sensitization to IR+EB 1089 treatment in p53 induced H1299 
(+Dox) (n=3, mean ± SE *p<0.05, #p<0.001 as compared to IR alone). Significant amounts 
of radio-sensitization was observed for the combination treatment of IR+ EB 1089 as 
compared to IR alone   
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Figure 5.4. Autophagy induction in p53 null (-Dox) H1299 cells. Acridine orange staining 
indicating acidic vesicle formation in response to IR and IR+EB1089 treatment in H1299 (-Dox) 
cells on day 3. (all images were taken at the same magnification. Moderate amounts of 
autophagy is induced by the IR and IR+EB 1089 treatments.  
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Figure 5.5. Autophagy induction in p53 induced (+Dox) H1299 cells. Acridine orange 
staining indicating acidic vesicle formation in response to IR and IR+EB1089 treatment in 
H1299 (+Dox) cells on day 3. (all images were taken at the same magnification).  
 
 
 
 
 
 
 
129 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 5.6. Inhibition of autophagy in p53 null (-Dox) H1299 cells by chloroquine. Inhibition 
of autophagy indicated by increased acidic vesicle formation with use of late stage autophagy 
inhibitor, chloroquine, in H1299 (-Dox) cells by day 3 (all images were taken at the same 
magnification). Being a weak base, chloroquine alters the pH of the acidic vesicles and can 
further lead to the color change in acidic vesicles from orange to yellow. 
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Figure 5.7. Inhibition of autophagy in p53 inducible (+Dox) H1299 cells by chloroquine.  
Inhibition of autophagy indicated by increased acidic vesicle formation with use of late stage 
autophagy inhibitor, chloroquine, in H1299 (-Dox) cells) on day 3. (all images were taken at the 
same magnification). Being a weak base, chloroquine alters the pH of the acidic vesicles and can 
further lead to a color change in vesicles from orange to yellow. 
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Figure 5.8. Inhibition of autophagic flux in H1299 cells by western blotting. Interference 
with autophagic flux as indicated by accumulation of LC3II by Western blotting in H1299 (-Dox) 
and (+Dox) cells on day 3. Accumulation of LC3II indicates accumulation of autophagosomes.   
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Figure 5.9. Blocking autophagy reverses the sensitization in p53 inducible (+Dox) H1299 
cells. Cell viability studies indicating no change in sensitivity upon autophagy inhibition in p53 
null H1299 (-Dox) cells (upper panel). Cell viability studies indicating reversal in sensitivity upon 
autophagy inhibition by pharmacological inhibitor, chloroquine,  in p53 induced H1299 (+Dox) 
cells (lower panel) (n=3, mean ± SE; *p<0.05; #p<0.001). These studies were carried out for a 
time period of 7 days.  
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Figure 5.10. Genetic knockdown of autophagy genes H1299 cells. Western blotting 
indicating knock down of autophagy genes ATG5  (upper panel) and BECN1 (lower panel) in 
both H1299 (-Dox) and H1299 (+Dox) cells.  
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Figure 5.11. Autophagy inhibition in p53 null (-Dox) H1299 cells by knockdown of 
autophagy related genes. Acridine orange staining indicating inhibition of autophagy after 
ATG5 and BECN1 knockdown in H1299 (-Dox) cells on day 3. Orange color indicating 
acidic vesicles is significantly reduced when autophagy genes are knocked down in 
response to IR and combination treatment of IR+ EB 1089.  
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Figure 5.12. Autophagy inhibition in p53 inducible (+Dox) H1299 cells by knockdown of 
autophagy related genes. Acridine orange staining indicating inhibition of autophagy after 
ATG5 and BECN1 knockdown in H1299 (-Dox) cells Orange color indicating acidic vesicles is 
significantly reduced when autophagy genes are knocked down in response to IR and 
combination treatment of IR+ EB 1089.  
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Figure 5.13. Blocking autophagy by knocking down BECN1 reverses the sensitization in 
p53 inducible (+Dox) H1299 cells. Cell viability studies indicating no change in sensitivity upon 
autophagy inhibition in p53 null H1299 (-Dox) cells (upper panel). Cell viability studies indicating 
reversal in sensitivity upon autophagy inhibition by knocking down BECN1 in p53 induced H1299 
(+Dox) cells (upper panel) (n=3, mean ± SE; *p<0.05; #p<0.001). These studies were carried out 
for a time period of 5 days. 
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Figure 5.14. Blocking autophagy by knocking down ATG5 reverses the sensitization in p53 
inducible (+Dox) H1299 cells. Cell viability studies indicating no change in sensitivity upon 
autophagy inhibition in p53 null H1299 (-Dox) cells (upper panel). Cell viability studies indicating 
reversal in sensitivity upon autophagy inhibition by knocking down Atg5 in p53 induced H1299 
(+Dox) cells (lower panel) (n=3, mean ± SE; *p<0.05; #p<0.001). These studies were carried out 
for a time period of 5 days. 
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Figure 5.15. Induction in phosphorylation of AMPK in response to IR and IR+EB 1089 
treatments. Western blotting indicating changes in phosphorylation levels of AMPK in response 
to various treatments at early time points, 4  and 12 hours. Phospho-AMPK is significantly up 
regulated as early as 4 hours and stays so till 12 hours.  
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Figure 5.16. Assessment of changes in AMPK phosphorylation by flow cytometry. 
Assessment of phosphorylation of AMPK (Thr172) by flow cytometry at 4 and 12 hours post-
radiation (n=3, mean ± SE, *p<0.05, #p<0.001). Significant increase In phospho-AMPK levels 
with the combination treatment of IR+ EB 1089 as compared to EB treatment alone at 4 and 
12 hours is observed.  
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Figure 5.17. Inhibition of phosphorylation of AMPK and ACC by compound C. Western 
blotting indicating inhibition of phosphorylation of AMPK and its downstream target acetyl-CoA 
carboxylase (ACC) by compound C (inhibitor of AMPK).  Samples were collected 12 hours 
after different treatments were given. 
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Figure 5.18. Minimal effect of compound C on cell viability. Cell viability studies 
indicating minimal growth inhibitory effects of compound C used at 5µMconcentration in H460 
cells (n=3, mean ± SE). Cells were treated with compound C for 48 hours and cell viability 
was assessed over a time period of five days.  
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Figure 5.19. Assessment of GFP-LC3 redistribution after inhibition of AMPK using 
compound C.  GFP-LC3 transfected H460 cells were exposed to 100 nM EB 1089 and IR 
(6Gy) treatment with and without compound C (5µM). 12 hours after treatment cells were fixed 
and counterstained with DAPI and visualized using confocal microscope.  
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Figure 5.20. Effects of pharmacological inhibition of AMPK on cell viability. Cell viability 
studies conducted to assess the effects of Compound C (5µM) on the temporal response to 
radiation (IR, 6 Gy) alone or EB 1089 + radiation in h460 cells (n=3, mean ± SE, *p<0.05, 
#p<0.001). Inhibiting AMPK in response to IR treatment, cell were sensitized as indicated by a 
reduction in cell count. However, inhibiting AMPK in response to IR+EB 1089, resulted in reversal 
of sensitization.  
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5.3. Summary. 
Studies conducted in p53 mutant and p53 null cell lines, H358 and H1299, indicate the 
importance of wild-type p53 in order to sensitize tumor cells to radiation using vitamin D 
and its analogues. Lack of sensitization in p53 mutant and null cell lines and regain of 
sensitivity in H1299 cells when p53 was expressed led us to our conclusion. We 
employed both pharmacological inhibition and genetic inhibition of autophagy to study 
the interlink between autophagy, p53 and radaiosensitization in NSCLC cells.  
Studies assessing levels of AMPK indicated its involvement in both IR and IR + EB 
1089 induced autophagy although the increase was significantly higher for the 
combination treatment. Levels of phosphorylated ULK-1 also appeared to be higher for 
the combination treatment as compared to IR treatment alone. Treatment with 
compound C, a pharmacological inhibitor of AMPK, resulted in decreased autophagy 
and reversed radiosensitization obtained with the combination treatment. Furthermore, it 
increased sensitization when used for radiation alone, complementary to our earlier 
studies done with pharmacological and genetic inhibition of autophagy. These studies 
suggest that AMPK is involved and plays an important role in both functions of 
autophagy but does not appear to be the differentiating factor between the two forms, 
cytoprotective and cytostatic. However, since pharmacological inhibitors can have off 
target effects, studies using a genetic approach to inhibit AMPK will be done to validate 
these findings.  
 
 
 
145 
 
 
 
Chapter 6 
Discussion 
The treatment of lung cancer continues to represent a clinical challenge.  While current 
treatments do often prolong patient life, these therapies almost invariably become 
primarily palliative (Saintingy P, et al. 2012; Wintner LM, et al. 2013).   Therefore, there 
is a compelling need to identify and develop strategies to make the existing treatments 
more effective.  
Radiation is the gold standard lung cancer treatment (Cai S, et al. 2014; Bayman N, et 
al. 2013; Hamamoto Y, et al. 2012); however, disease recurrence has always been an 
issue. One of the main goals of our laboratory has been to develop strategies to 
attenuate the recovery of tumor cells after radiation treatment. In addition, the doses of 
radiation that can be administered are limited by toxicity to normal adjoining tissue (Van 
Kaick G, et al. 2008).  Consequently, increasing the selectivity of radiation therapy 
would be of great benefit to lung cancer patients. 
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A number of studies in the past have been reported on the effectiveness of combining 
1,25-D3 or vitamin D analogues with conventional chemotherapies such as Tamoxifen 
or Adriamycin against a variety of tumors in preclinical studies (Hershberger PA, et al, 
2001; Wang Q, et al, 2000; Light BW, et al. 1997). Vitamin D alone has been shown to 
have anti-proliferative effects in various experimental models of cancer (Krishnan AV, et 
al. 2012; Ramnath N, et al. 2011). However, in our hands, 1,25-D3 or EB 1089 alone, at 
100nM, showed no antiproliferative or cytotoxic effects against the NSCLC cell lines 
(H460, A549, H1299 and H358) used in the current work despite high expression of the 
vitamin D receptor; this highlights that fact that the effects of the combination treatments 
are not merely additive but reflect a mechanistic interaction that is likely to be related to 
the induction of autophagy (since vitamin D by itself has minimal inhibitory effects on the 
growth of cells).  
It is important to emphasize that our studies differ from other in which vitamin D alone 
had effects on cell growth or viability in that we do not utilize a continuous treatment;  
vitamin D  and EB 1089 are removed from cells after 48 hours. Furthermore,  the dose  
used in our work (100 nM) is not in the high physiological range and can be achieved 
pharmacologically in patients (Ilahi M, et al. 2008; Hillyer RL, et al. 2012) 
Similar to the findings with breast tumor cells, the presence of the VDR is critical since 
studies conducted with p53 wild-type H838 NSCLC cells, which lack the vitamin D 
receptor, showed lack of radio-sensitization with the combination treatment. 
Drug selectivity and specificity are critical elements in efforts to avoid damage to normal 
tissue. Non-specific drug effects can result in off-target actions causing severe and 
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undesired side effects. We showed that vitamin D does not increase radiation sensitivity 
in normal bronchial epithelial cells in spite of their expression of the vitamin D receptor 
(Jeong Y, et al. 2012) or in H9C2 cardiomyocytes which have wild-type p53 (Yang YF, 
et al. 2011), the latter being relevant in cases where the heart might fall within the 
radiation field during the course of treatment.  
Previous work from our laboratory has shown that vitamin D has the capacity to 
enhance radio-sensitivity in breast tumor cells (Bristol ML, et al. 2012; Wilson EN, et al. 
2011; Demasters GA, et al. 2004; Sundaram S, et al. 2003), mainly through promotion 
of autophagy (Bristol ML, et al. 2012; Wilson EN, et al. 2011; Demasters GA, et al. 
2006). We sought to extend these findings to non-small cell lung tumor cells, which are 
relatively resistant to radiation treatment. Our studies provide support for the potential 
use of vitamin D in the development of adjuvant therapy for non-small cell lung cancer 
treatment.  
6.1 Sensitization to radiation:  
One of the most common responses to stress generated by radiation is DNA damage, 
where radiation results in either single strand or double strand breaks (Ward JF, et al. 
1998). Therefore, we first used flow cytometry to assess DNA damage in response to 
radiation treatment by quantifying the amount of phosphorylated γ-H2AX. We observed 
an increase in DNA damage as early as 1 hour after irradiation of the cells, which then 
was quickly repaired. However, there was no difference either in the extent of initial 
DNA damage or the rate or repair for radiation alone and vitamin D + radiation. 
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While the combination treatment of radiation + 1,25D3 or EB 1089 resulted in cell death 
in breast tumor cells (Bristol ML, et al. 2012; Wilson EN, et al. 2011), in the current 
studies we observe primarily extended growth inhibition and suppression of proliferative 
recovery. One of the reasons for this difference could be because lung tumors are 
known to be relatively more radio-resistant as compared to breast tumors  
The combination treatment of radiation + 1,25D3 or EB 1089 did not increase either 
apoptosis or necrosis, similar to what we have reported previously for breast tumor cells 
(Bristol ML, et al. 2012; Wilson EN, et al. 2011). In contrast to the studies in breast 
tumor cells, there was no evidence of cell death (i.e. a decline in viable cell number over 
time). Nevertheless, we observed unequivocal evidence for radio-sensitization in 
clonogenic survival assays, which is consistent with a reduction in the capacity for 
cellular self-renewal. The observed impact on self-renewal capacity and proliferative 
recovery could prove to be relevant to the problem of disease recurrence in lung cancer 
patients.  
Since our cell viability studies indicate a primary response of growth inhibition and 
studies suggest induction of senescence in response to radiation in breast tumor cells 
(Jones KR, et al. 2005; Wilson EN, et al. 2011), we used beta-galactosidase staining to 
assess levels of senescence in A549 and H460 cell lines. We also employed flow 
cytometry to quantify the extent of senescence. Although senescence induction was 
evident with both IR and IR+ 1,25-D3/EB 1089 treatments, we did not observe a 
significant increase in senescence when radiation was combined with 1,25-D3 or EB 
1089.  
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Since we have previously shown that sensitization in breast tumor can occur by 
induction of autophagy, induction  of autophagy was shown in the non-small cell lung 
cancer models using multiple complementary assays including acridine orange 
staining/flow cytometry, GFP-LC3 puncta formation by confocal microscopy and 
western blotting to estimate levels of autophagic flux related proteins, LC3II and p62.  
6.2 Radiation treatment alone induces cytoprotective function of autophagy.  
A number of studies in the literature support the premise that autophagy produced in 
response to radiation is cytoprotective in nature (Ko A, et al. 2014; Apel A, et al. 2008; 
Cheng G, et al. 2013). We have confirmed that radiation-induced autophagy is 
cytoprotective in our cell models as the cells are sensitized to radiation when autophagy 
is blocked using either pharmacological inhibitors such as chloroquine and bafilomycin 
or genetic tools to knockdown autophagy genes, ATG5 and BECN1.  
We performed cell viability studies to study the growth profile and performed 
annexinV/PI staining to estimate alterations in levels of apoptosis when autophagy was 
blocked. Induction of apoptosis when autophagy is inhibited has been shown previously 
in the literature (Cheng G, et al. 2013). Studies by Apel A, et al. (2008) demonstrated 
the cytoprotective nature of autophagy in A549 NSCLC cells. Interestingly, this effect 
was more pronounced in cells with wild-type p53. We observed a similar trend  in our 
studies where we obtain cytoprotective autophagy in response to radiation in wild-type 
p53 cell lines, A549 and H460. 
In a study published by Kroemer’s research group (Kroemer G, et al. 2008), it is argued 
that autophagic cell death does not exist and that autophagy simply constitutes a death 
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effector mechanism when upstream of other cell death pathways such as apoptosis or 
necrosis.  This work supports a pro-survival/protective role of autophagy produced in 
response to radiation alone (Kroemer G, et al. 2008).  
Although our studies of radiation-induced autophagy are consistent with a cytoprotective 
function, we observe a novel form/function of autophagy when vitamin D is employed in 
combination with the radiation treatment. We have termed this new form “cytostatic” 
since it is associated with enhanced growth arrest upon IR + 1,25-D3/EB 1089 
treatment as shown in cell viability studies. Of particular importance, inhibition of this 
form/function of autophagy leads to a reversal in sensitization. Furthermore, we do not 
observe any induction in cell death modes such apoptosis or necrosis  with the 
combination treatment.   
6.3 Radio-sensitization by vitamin D caused by a change in the function of 
autophagy.  
While our initial experiments in A549 cells suggested that sensitization might be related 
to an increase in the extent of autophagy, since we see significant differences in 
autophagy levels with radiation alone and the combination treatment of IR and 1,25-D3, 
subsequent experiments in H460 cells tended to rule out this possibility; that is, there 
was only a minimal and largely non-significant increase in the extent of autophagy with 
the combination treatment  
I Inhibition of autophagy induced in response to the combination treatment of IR and EB 
1089 using both pharmacological and genetic tools led to a reversal in sensitization in 
H460 cells.  These findings in particular support the relatively novel premise that the 
151 
 
cytoprotective function of autophagy that is evident with radiation alone is converted to a 
cytostatic function (pronounced growth inhibition, suppression of proliferative recovery 
and reduced clonogenic survival) with the combination treatment of IR and EB 1089. 
This conclusion is supported by the observations that inhibition of autophagy sensitizes 
the cells to radiation alone but protects the cells from the combination treatment. Our 
argument for the conversion of one form of autophagy to the other is  that sensitization 
to radiation through autophagy inhibition appears to have been entirely eliminated from 
the experimental system; otherwise, we might have expected sensitization to radiation 
by inhibition of the protective autophagy induced by radiation alone to have masked the 
reversal of sensitization to EB 1089 or 1,25-D3 when cytostatic autophagy was inhibited. 
If radiation induced cytoprotective autophagy was still prevalent in response to the 
combination treatment, then inhibition of the autophagy induced in response to the 
combination treatment would  not result in reversal of the sensitization to radiation.  
This idea of a switch in autophagic function has also been reported previously in the 
literature.  The combination treatment of vitamin D and IR has been shown to cause 
autophagy to switch from a cytoprotective to a cytotoxic function in breast tumor cells 
(Wilson EN, et al. 2011; Bristol ML, et al. 2012). Certain chemotherapies such as 
topotecan and camptothecin have been reported to cause similar changes in the 
function of autophagy from cytoprotective to cytotoxic in colon carcinoma cells and 
osteosarcoma cells (Li DD, et al. 2012; Hollomon MG, et al. 2013). Although the 
mechanisms underlying these changes have not yet been identified,  these studies 
indicate that autophagy can demonstrate opposing functions in a particular 
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malignancy/cancer cell type and therefore, increase the challenge of exploiting the 
radiation or chemotherapy induced autophagy for therapeutic gain.  
6.4 Efforts to identify signaling pathways associated with autophagy: 
Our previous work established that p53 is required for sensitization to radiation by 
vitamin D in breast tumor cells (Bristol ML, et al. 2012; Wilson EN, et al. 2011) and this 
appears to be the case for NSCLC cells as well, since H358 cells with mutant p53 did 
not demonstrate any radio-sensitization by EB 1089.  Furthermore, sensitization to 
radiation by EB 1089 could not be shown in the p53 null, VDR expressing H1299 cell 
line unless p53 expression was induced under the influence of doxycycline. A linkage 
between p53 status and the biological impact of vitamin D has been reported previously 
(Stambolsky P, et al. 2010). These studies demonstrated that mutant p53 could convert 
the anti-proliferation effects of vitamin D into pro-proliferation effects, which could 
potentially explain the lack of sensitization in the absence wild-type p53. Therefore, 
there seems to be a requirement for wild-type functional p53 for vitamin D to able to act 
as a radio-sensitizer and produce its anti-proliferative effects.  
Another study reported by Reichrath J et al.(2014) indicated that there is evidence of 
crosstalk between vitamin D signaling and p53. Both p53 and VDR act as transcriptional 
regulators, which are present at the core of the common network involved in regulation 
of proliferation, survival and homeostasis. VDR has been shown to have a p53 binding 
sites (Maruyama R, et al. 2006). The literature suggests that wild-type p53 can lead to 
activation and induction of VDR. VDR and p53 engage in physical interaction (indicated 
by co-immunoprecipitation), which has been shown to be significantly enhanced in the 
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presence of vitamin D (Maruyama R, et al. 2006; Stambolsky P, et al. 2010). Regulation 
of both p53 and VDR can lead to alteration of a number of p53 target genes 
(Stambolsky P, et al. 2010). Taken together, these studies suggest that the interaction 
of functional p53 and VDR might be playing a role in 1,25 D3/EB 1089 induced radio-
sensitization by altering their downstream targets.  
There are multiple signaling pathways that can  mediate the link between cellular 
damage and autophagy, and p53 appears to play a dual in this crosstalk (Sui X, et al. 
2011).  p53 is involved in regulating autophagy through transcriptional activation of the 
AMP-activated protein kinase (AMPK), which is a potent inducer of autophagy (Cheng 
G, et al. 2013; Alexander A, et al. 2011; Feng Z, et al. 2005). The requirement for 
functional p53 is consistent with the apparent involvement of AMPK in autophagy as 
p53 has been shown to act upstream of AMPK (Cheng G, et al. 2013; Lorin S, et al. 
2013). Additionally, Feng et al. (2005) showed activation of AMPK in a p53 dependent 
manner and further indicated that p53 can bind to the promoter of β subunit of AMPK as 
it has a consensus p53 binding site (Feng Z, et al. 2007). . However, this activation 
appears to be stress specific as it occurs in response to UV radiation but not when 
Adriamycin treatment is given (Feng Z, et al. 2007). In our studies, p53 appears to be 
essential for activation of AMPK but we do not yet have evidence that p53 directly 
promotes phosphorylation of AMPK since transactivation would be expected to induce 
an increase in levels of AMPK To investigate p53’s involvement further, we would plan 
to transfect p53 null H1299 cells with p53 mutated specifically in its transactivation 
domain to determine whether p53 acting as a transcriptional activator (possibly at other 
target sites) is responsible for AMPK activation ( phosphorylation).  
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AMPK can also be activated by CaMKKβ (Ca2+/calmodulin-dependent kinase kinase β) 
(Woods A, et al. 2005; Hawley SA, et al. 2005), upon recognition of increased Ca2+ 
levels, which has been linked to vitamin D (Hoyer-Hansen et al. 2007). Furthermore, 
studies have implicated radiation in the activation of AMPK (Sanli T, et al. 2010). In 
efforts to define the pathways involved in sensitization effects of vitamin D, we designed 
studies to identify and establish AMPK mediated autophagy, as both vitamin D and 
radiation are involved in AMPK regulation. Additionally, studies in MCF-7 breast tumor 
cells have shown proof of up-regulation of phospho-AMPK and phospho-ULK-1 in 
response to the combination treatment of radiation and 1,25-D3 as compared to 
radiation treatment alone (manuscript in press). 
Experiments were conducted to study changes in phosphorylation levels of AMPK in 
response to IR or the combination treatment of IR+EB 1089 in H460 cells. Assessment 
of AMPK activity revealed up-regulation of phosphorylated AMPK (Thr172 
phosphorylation site) as early as 4 hours after exposure to both IR and IR+EB 1089 
treatments but the increase was much more significant for the combination treatment. 
These findings implicate the AMPK pathway in the induction of cytostatic function of 
autophagy in response to the combination treatment of radiation and EB 1089.  
To further establish/study AMPK’s role in autophagy induced by radiation and radiation 
+ vitamin D/EB 1089, we studied the effects of the pharmacological inhibitor of AMPK, 
compound C (Zhou G, et al. 2001) on the growth kinetics of cells.  Western blotting 
confirmed compound C ‘s ability to inhibit phosphorylation of AMPK and its downstream 
target acetyl-CoA carboxylase (ACC). Inhibition of autophagy was confirmed by 
attenuation of GFP-LC3 redistribution when compound C was used in combination with 
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IR and EB 1089. Studies monitoring cell viability suggested that inhibition of AMPK by 
compound C also sensitized the cells to radiation while protecting the cells from the 
combination treatment of radiation + EB 1089, complementary to the studies assessing 
the impact of more direct autophagy inhibition. Our studies indicated that blocking 
autophagy by inhibiting AMPK phosphorylation leads to a reversal in sensitization in 
response to the combination treatment of IR + EB 1089 but an increase in sensitization 
in response to IR, further strengthening the idea/concept of two different functions of 
autophagy.  
The observation that blocking AMPK phosphorylation using compound C was able to 
alter the functions of autophagy for both IR and the combination treatment of IR+EB 
1089 suggests that AMPK might not be the distinguishing factor between the two 
different functions of autophagy. However, AMPK definitely appears to play a role in 
vitamin D mediated sensitization and provides valuable insight into the signaling 
pathways being activated leading to autophagy by IR and the combination treatment of 
IR + EB 1089.   
One of the most interesting and novel findings of our studies is the switch in function of 
autophagy from cytoprotective in response to radiation to cytostatic in response to IR+ 
EB 1089. One of the simple explanations for this switch could be that the initial 
response to stress in a system is protective in nature where the cell is trying to maintain 
homeostasis and activates all the pro survival mechanisms but when the stress 
becomes intolerable (as might be the case with the combination treatment) and 
homeostasis cannot be maintained, the function changes from being protective to 
static/toxic where either arresting the growth of cells or destroying them is the only 
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alternative.  One other explanation could be that when cells are exposed to radiation, 
the initial tendency is towards self-protection, resulting in activation of signaling 
pathways that lead to induction of cytoprotective autophagy, However, the presence of 
vitamin D/EB 1089 is somehow masking the activation/up-regulation of some of these 
pathways and therefore causing the cells to undergo growth arrest to gain more time to 
repair the damage.    
6.5 Autophagy and senescence relationship?  
Studies in the literature have suggested a link between autophagy and senescence 
(Narita M, et al. 2009; Gewirtz DA, 2009; Young AR, et al.  2010). It would be interesting 
to examine the relationship between autophagy and senescence in the NSCLC model 
since the two processes occur at the same time. Furthermore, senescence has been 
implicated as a mechanism of autophagy-mediated dormancy (Lu Z, et al. 2008; 
Gewirtz DA, 2009). Selected autophagy genes such as ULK1 and ULK3 have been 
shown to be upregulated during senescence (Young AR, et al. 2009). Employing tools 
to inhibit autophagy and assess the effects on senescence is something we would like 
to do in the future.  
Previous studies  from our laboratory  also indicate that IR can induce senescence in 
breast tumor cells in a p53 dependent manner (Jones KR, et al. 2005).  Using the 
H1299 p53 null/inducible model could further shed some insight on the link/relationship 
between autophagy and senescence in the absence and presence of functional p53.  
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6.6 Clinical Trials 
A number of studies both in-vitro and in-vivo have demonstrated vitamin D’s ability to 
promote anti-tumor effects when used in combination with chemotherapy (McGuire MF, 
et al. 2001; Colston KW, et al. 1993; Wilson EN, et al. 2011). However there are a 
number of severe limitations when it comes to translating these findings to the clinic. 
Even though results from preclinical and clinical studies have indicated that high doses  
of vitamin D can be administered safely and feasibly either alone or in combination with 
other agents to enhance its anti-tumor activity (Woloszynska-Read A, et al 2011), the 
optimal dose or concentration that can be used safely in the clinic is yet to be 
determined. Possibly as a consequence of the fact that optimal doses of vitamin D were 
not used, a number of clinical trials did not succeed as expected (Flaig TW, et al. 2006; 
Beer TM, et al 2003; Muindi JR, et al. 2009). Furthermore, in our studies we have 
shown that both VDR and p53 are essential for vitamin D and its analog EB 1089 to 
mediate its growth inhibitory effects when used in combination with radiation. These 
studies indicate the need for stratification of patients based on their VDR and p53 status 
to improve the outcomes of any clinical trials involving vitamin D or its analogs.   
A recent clinical trial failed to demonstrate the advantage of combining calcitriol (vitamin 
D) with cisplatin in NSCLC, likely to be due to lack of stratification with regard to vitamin 
D receptor and p53 status in a relatively small cohort of near-terminal patients 
(Ramnath N, et al. 2013). As chemoradiation utilizing cisplatin and/or vinca alkaloids is 
the standard of care for NSCLC (Eberhardt W, et al. 2005), our future studies will 
include evaluation of the combination of 1,25-D3/EB 1089 with cisplatin/radiation and 
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vinca alkaloids/radiation in cell culture, which will ultimately be extended to tumor 
bearing animals.  
6.7 Future studies  
Clinical relevance of the use of vitamin D has been gaining attention over the last 
decade. Studies have suggested that 1,25-D3 is able to interfere with lung metastasis 
(Ingraham BA, et al. 2008). Expression of VDR and high circulating levels of the vitamin 
D precursor, 25(OH)D3 have been associated with prolonged survival in NSCLC cancer 
patients (Anderson MG, et al. 2006). Studies have further linked vitamin D deficiency to 
increased incidence and high mortality rates in breast, prostate and lung cancer patients 
(Abbas S, et al. 2008; Bertone-Johnson ER, et al. 2005; Lowe et al. 2005; Porojnicu et 
al. 2008). However, there is insufficient information as to the mechanisms underlying 
vitamin D’s ability to have anti-cancer effects when combined with either radiation or 
chemotherapy.  
There is an extensive amount of evidence in the literature implicating the ER stress 
pathway as being involved in autophagy induction (Digaleh H, et al. 2013). Studies have 
suggested that both 1,25-D3 and IR can induce ER stress (Hoyer-Hansen et al. 2007; 
Kim, K.W., et al. 2010). Our future studies will be designed to explore the ER stress 
pathway to determine if it is involved in the radio-sensitization effects produced by 
vitamin D and furthermore if this signaling pathway consists of factors that can 
differentiate between the two functions of autophagy.  
It is possible that vitamin D is able to sensitize tumor cells to radiation by activating 
multiple pathways to induce autophagy. Some studies conducted in breast tumor and 
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leukemia have suggested that 1,25-D3 has the ability to down regulate bcl-2 which is an 
anti-apoptotic gene and binds to an autophagy inducing gene, Beclin-1 (Van Leeuwan 
and Pols, 2005). Down-regulation of bcl-2 could lead to more free Beclin-1, which could 
explain why 1,25-D3 radio-sensitizes tumor cells by inducing autophagy.  
Another possible explanation for different functions of autophagy could be related to 
differences in selective cargo that is degraded in the autophagosome. Recently a study 
by Chen S, et al. (2014) indicated that inhibiting p62, which is a known signaling adapter 
and is involved in carrying ubiquitinated proteins and cellular components for 
degradation into autophagosomes, impairs the process of cargo loading into 
autophagosomes. Inefficient autophagy further leads to accumulation of the BH3-only 
protein NBK/Bik, which causes apoptosis. In order to  investigate whether the content of 
autophagosome is different (for radiation alone and EB 1089 + radiation)  we propose to 
isolate the autophagosome and analyze its contents by using mass spectrometry.  It is 
possible that when autophagy is protective in nature,  the autophagosome content is not 
harmful to the cells but when autophagy is cytostatic (or cytotoxic) in nature then the 
content released is harmful and the cells undergo growth arrest to repair the damage. 
We will also be performing parallel studies using another approach of proteomics (mass 
spectrometry) to complement this effort. Specifically our goal would be to identify 
phosphoproteins that distinguish between cytoprotective and cytostatic functions of 
autophagy in order to ultimately use these as biomarkers in the clinic to predict which 
tumors would be susceptible to autophagy inhibition as a strategy for sensitization to 
radiation.  
160 
 
A recent review indicated that the subunits of AMPK, α1 and α2, could have different 
localization patterns, with the α2 subunit being localized in both nucleus and cytoplasm 
and α1 being restricted to the cytoplasm (non-nuclear fraction) (Kazgan et al. 2010; 
Alexander A, et al. 2011). Although previous studies conducted in our laboratory in 
breast tumor cells showed an increase in both nuclear and cytoplasmic localization of 
AMPK in response to the combination treatment of IR and vitamin D (data not 
published), there is a possibility that α1 and α2 are being differentially regulated by the 
combination treatment, which could be playing a role in changing the function of 
autophagy. p27, a cyclin dependent kinase inhibitor, is a direct downstream target of 
AMPK and induces growth arrest by inhibiting cell cycle progression when activated in 
the nucleus (Alexander A, et al. 2011). It could be possible that the cytostatic function of 
autophagy involves up-regulation of AMPK α2, causing cells to undergo growth arrest in 
response to the combination treatment. We have adenoviruses that express dominant 
negative α1 and α2 isoforms and inhibition of each isoform will be employed to test this 
hypothesis.   
Another kinase that has been shown to regulate autophagy is ULK-1, which can be 
directly activated by AMPK. A study by Kim et al. (2011) demonstrated a molecular 
mechanism for regulation of ULK-1 (Jung et al 2010; Kim et al. 2011). Under starvation, 
AMPK promotes phosphorylation of ULK-1 at Ser317 and Ser777, which leads to up-
regulation of autophagy (Jung et al 2010; Kim et al. 2011). Under nutrient sufficiency, 
high mTOR activity leads to down-regulation of autophagy by phosphorylating ULK-1 
Ser757, which disrupts the interaction between ULK-1 and AMPK (Jung et al 2010; Kim 
et al. 2011). We would assess levels of both ULK-1 and mTOR to extend and identify 
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differences in the signaling pathways involved in the two different functions of 
autophagy. 
We also intend to expand these studies to tumor bearing animal models where its 
pharmacokinetics (absorption, distribution, metabolism, and excretion) will play an 
important role in its ability to radio-sensitize tumors. Consequently, we intend to perform 
initial studies to carefully determine the dose range to be employed in animals. We 
propose to utilize one cell line where vitamin D confers sensitization to radiation  
(H1299/p53 inducible) and one where vitamin D is ineffective (H1299/p53 null cells) and 
their isogenic counterparts where autophagy has been genetically inhibited by knocking 
down autophagy related genes such as atg5 and Beclin-1. The two tumor cell lines 
(autophagy deficient and autophagy proficient) will be grown as xenografts in opposing 
flanks, and irradiated providing a direct assessment of sensitization by vitamin D.  
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6.8 Summary 
The current work builds upon and extends our previous findings in breast cancer in 
demonstrating that 1,25-D3 and the vitamin D analog EB 1089 enhance sensitivity to 
radiation in NSCLC cells. Again, as in previous work, sensitization is limited to NSCLC 
cells that express the vitamin D receptor and functional p53. Furthermore, there is no 
apparent sensitization in normal lung epithelial cells or cardiomyocytes, consistent with 
previous work that indicated that sensitization did not occur in non-transformed cells 
(Polar MK et al. 2003). The current work also is similar to our previous findings in 
implicating autophagy as the mechanism underlying the radio-sensitization. However, in 
contrast to the promotion of a cytotoxic form of autophagy in breast tumor cells (Bristol 
ML, et al. 2012; Wilson EN, et al. 2011; Demaster GA, et al. 2006), we present the 
novel observation that the autophagy induced by radiation in combination with either 
1,25-D3 or EB 1089 has a cytostatic function that nevertheless translates into an 
enhanced reduction of clonogenic survival. Finally, in these studies, we observe the 
apparent conversion of the cytoprotective form of autophagy induced by radiation alone 
to the cytostatic form by radiation in combination with +1,25-D3 or EB 1089.  
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